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Abstract 
Three-dimensional (3D) in vitro cell culture models capturing both the structural and 
dynamic complexity of the in vivo situation are in great demand as an alternative to animal 
models. Despite tremendous progress in engineering complex tissue/organ models in the 
past decade, approaches that support the required freedom in design, detail and chemistry 
for fabricating truly 3D constructs have remained limited. Here, we report a 
stereolithographic high-resolution 3D printing technique utilizing poly(ethylene glycol) 
diacrylate (PEGDA, MW 700) to manufacture diffusion-open and mechanically stable 
hydrogel constructs as self-contained chips, where confined culture volumes are supplied 
with oxygen and nutrients by perfusable vascular-like networks. An optimized resin 
formulation enables printing of hydrogel chips with perfusable multi-furcated microchannel 
networks, and the printed microchannels can be steadily perfused for at least one week. In 
addition, the integration of multiple independently perfusable and structurally stable 
channel systems further allows for easy combination of different bulk material volumes at 
exact relative spatial positions. We demonstrate this structural and material flexibility by 
embedding a highly compliant cell-laden gelatin hydrogel within the confines of a 3D printed 
resilient PEGDA hydrogel chip of intermediate compliance.  Overall, our proposed strategy 
represents an automated, cost-effective and high resolution technique to manufacture 
complex 3D constructs containing microfluidic perfusion networks as advanced in vitro 
models for various biomedical applications such as drug development and in vitro disease 
modeling. 
Multi-material stereolithographic printing based on epoxy and acrylate has also been 
demonstrated. Perfusion chips composed of a stiff epoxy component as structural supports 
interfacing the external world as well as compliant PEGDA component as microfluidic 
channels have been manufactured and perfused. Although still in the preliminary stage, this 
dual-material printing approach shows the potential for constructing complex 3D structures 
with heterogeneous components fulfilling different purposes. 
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Dansk resumé 
Tre-dimensionelle (3D) in vitro celledyrkningsmodeller, der afspejler både den 
strukturelle og dynamiske kompleksitet af in vivo miljøer, er efterspurgt som et alternativ til 
dyremodeller.   På trods af store fremskridt i udvikling af komplekse vævs-/organ-modeller i 
det forløbne tiår har kun et fåtal af de udviklede metoder kunnet bidrage med tilstrækkelige 
frihedsgrader i design, detaljegrad og kemi til at kunne fremstille sande 3D 
dyrkningsenheder. Vi beskriver her en stereolitografisk høj-opløst 3D printningsmetode der 
gør brug af poly(ethylenglykol) (PEGDA, 700 g/mol) til at fremstille diffusionsåbne og 
mekanisk stabile hydrogelenheder som selvstændige chips, hvor afgrænsede 
dyrkningsvolumener bliver forsynet med oxygen og næringsstoffer fra 
væskegennemstrømning i blodkars-lignende netværk af kanaler. En optimeret 
sammensætning af den anvendte printevæske tillader printning af hydrogel-chips som har 
gennemstrømbare mikrokanaler med et tværsnit på ned til 100 µm x 100 µm, og de printede 
mikrokanaler kan gennemstrømmes med dyrkningsvæske i mindst en uge. Yderligere tillader 
integration af separate uafhængige kanalsystemer i chipenheden at forskellige volumener i 
enheden kan fyldes med forskellige materialer med stor indbyrdes rumlig præcision. Vi 
demonstrerer denne fleksibilitet i struktur og materialer ved at indlejre en meget mekanisk 
eftergivende celle-fyldt gelatine hydrogel i et defineret hulrum i en 3D printet PEGDA 
hydrogel chip af middel eftergivenhed. Overordnet set udgør vores foreslåede tilgang en 
automatiseret, omkostningseffektiv og høj rumligt opløst metode til at fremstille komplekse 
3D enheder indeholdende mikrofluide kanalnetværk, som kan anvendes som avancerede in 
vitro modeller i en række biomedicinske anvendelser så som medicinudvikling og in vitro 
sygdomsmodeller. 
Fler-materiale stereolitografisk printning baseret på epoxy- og akrylat-udgangsmaterialer 
er også blevet demonstreret: Chips med mikrofluide kanaler er blevet fremstillet, hvor en 
printet stiv epoxy-baseret komponent er anvendt som strukturel understøttelse som 
grænseflade til omverdenen og en printet middel eftergivende PEGDA komponent fungerer 
som vægge i mikrofluide kanaler. Væskegennemstrømning af de printede mikrokanaler er 
efterfølgende vist. Disse foreløbige resultater fra fler-materiale printning illustrerer 
potentialet for at fremstille komplekse 3D strukturer med forskellige komponenter der 
opfylder forskellige krav. 
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Chapter 1:  
Introduction 
1.1 Motivation and project goal 
During the past decades, biomedical research has flourished in many aspects, from cell 
and molecular biology that aims to promote better understanding of human physiology, to 
drug development that aims to provide better therapeutics, and ultimately to tissue 
engineering that aims to replace damaged tissues or organs. Cell culture model, as an 
essential component in all of those abovementioned research fields, plays an important role 
in unraveling the complexity of biological systems. 
Much progress has been made in cell culture models, from traditional 2D monolayer 
cultures to well-engineered 3D culture models. The most common substrates for supporting 
cell growth have been made from polystyrene and glass and have taken the form of a flat 
two-dimensional (2D) surface.1 Such robust and convenient approach has been routinely 
adopted by researchers for their daily work, and it has contributed greatly to our 
understanding of basic cell and molecular biology. In the meantime, its overly simplistic 
nature has frequently raised doubts about how relevant it is for interpreting the information 
obtained compared to the extremely complex native biological systems. Therefore, the 
importance of a 3D cell culture model has been widely recognized and techniques that can 
achieve 3D cell culture are in great demands. 
The key challenge in constructing functional 3D culture models is vascularization. Native 
tissues and organs are supplied with oxygen and nutrients through an intricate vascular 
network which constantly delivers convective blood flow locally, while the maintenance of 
cells cultured in vitro within a 3D environment is mainly dependent on the slow diffusion of 
soluble factors from the surrounding culture medium. Therefore, a healthy in vitro 3D cell 
culture at a physiologically relevant scale remains a major challenge. 
With the advent of 3D printing techniques, fabrication of 3D cell culture models with 
embedded artificial vascular-like channel network has become possible. There are many 
existing 3D printing techniques, all of which have their own advantages and disadvantages. 
Therefore how to choose suitable materials and techniques takes much consideration 
depending on models of interest and intended applications. While some techniques focus on 
biological relevance and complexity, others focus on manufacturability. Ideally, a balance 
needs to be well kept so that an adequately complex system can also be manufactured in a 
cost-efficient, automated and user-friendly manner, which would make it easier to 
disseminate outside research labs and ultimately contribute to the social welfare. 
In addition, although the ability to manufacture exact replicas of natural tissue or organs 
in vitro is extremely attractive, we are still far away from that stage. A currently more 
realistic aim is to provide enough functionality for those constructed culture models to serve 
as clinically useful replacements for damaged tissues or as in vitro models for scientific 
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studies such as disease modeling and drug development. Since native cellular systems are 
very complex, the degree to which researchers must control the cellular microenvironment 
to elicit desired biological response is still largely unclear,2 and there will be a continuing 
process that involves model construction and model validation.  
Motivated by all those challenges and inspirations discussed previously, the goal of this 
PhD project is to develop a facile and reproducible 3D printing-based fabrication platform 
for vascularized 3D cell culture models that aim to serve as in vitro tissue models for 
applications such as drug screening and in vitro disease modeling rather than in vivo 
implants. More specifically, we aim to use stereolithographic 3D printing to manufacture 
diffusion-open and mechanically stable hydrogel constructs as self-contained 3D microfluidic 
chips, where confined cell culture units are supplied with oxygen and nutrients through 
independently perfusable vascular-like networks, as illustrated in green for the culture unit 
and in red for the perfusion network in Figure 1.1. The goal of the project is further divided 
into the following tasks: 
1. Develop a suitable cost-efficient resin for printing diffusion-open yet mechanically stable 
hydrogel constructs with embedded true 3D microfluidic channel networks of 
physiologically relevant sizes. 
2. Develop a facile platform for steady and long-term perfusion of constructed hydrogel 
chips. 
3. Develop a platform for long-term perfusion cultures of cells within constructed hydrogel 
chips. 
 
The present progress in the field as well as existing techniques used for 3D cell cultures 
are reviewed in the following sections. The 3D printing technique used in this project, 
stereolithography, as well as the current challenges that motivate us to carry out this project 
are highlighted. 
 
Figure 1.1 A) A schematic diagram of a generic 3D hydrogel microfluidic chip design containing a cell 
culture unit (green) surrounded and traversed by a perfusion fluidic channel network (red). B) Wide-
field fluorescence image (top view) of the printed 3D microfluidic chip showing the vascular-like 
Perfusion network 
outlet Culture unit 
outlet
Perfusion network 
inlet
Culture unit 
inlet
A B
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network coated by rhodamine (red) and the chamber filled with live fibroblasts (green)-laden gelatin 
hydrogel, as well as confocal fluorescence images of a cross-sectioned slice of the printed hydrogel 
chip showing the perfused vascular-network (red), live fibroblasts (green) and the printed hydrogel 
chip outline (transmitted light, grey).   
           
1.2 Why transition from 2D to 3D? 
Cell culture is essential to many biomedical studies including cell biology, pathology, 
tissue engineering as well as development of therapeutic drugs.3 So far cell culture studies 
have mainly been performed in a form of cellular monolayer on 2-dimensional (2D) planar 
surfaces, such as polystyrene well plates, flasks and Petri dishes. Those conventional 2D cell 
culture systems represent a convenient, affordable and robust technical platform that has 
been extensively adopted by researchers and has notably improved the understanding of 
human biology and disease.4 However, in the body, nearly all cells reside in a 3D 
microenvironment composed of vasculature enabling oxygen and nutrients supply as well as 
metabolic wastes removal, soluble factors, cell-extracellular matrix (ECM) interactions and 
cell-cell communications (Figure 1.2).5 Those elements constitute the specific cell 
microenvironment and work in concert to regulate various cellular behaviors and 
functionalities. Conventional 2D culture systems fail to recapitulate such complex 
microenvironment and subsequently often produce misleading results in predicting in vivo 
responses. It is now commonly accepted that cells cultured in their native 3D environments 
behave differently compared to those cultured in 2D in many cellular processes, such as 
morphology, proliferation, migration and drug sensitivity.6 As a result, 3D cell culture models 
that better mimic in vivo conditions are in great demand. 
 
Figure 1.2 The cell microenvironment is composed of multiple elements. For example, the 
endothelium that lines blood vessels is exposed to hemodynamic shear stress (external physical force) 
that stimulates a biochemical response. Soluble factor molecules diffuse to neighboring smooth 
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muscle cells (SMCs), where they regulate cell contraction and relaxation. The gradient of diffused 
soluble factors affect nearby SMCs more than distant SMCs. Endothelial cells are anchored to the 
basement membrane, while SMCs are anchored to the ECM of the interstitium, both through 
integrins that act as sensors and transducers of physical force. Local physicochemical properties 
ensure proper regulation of both physical and biochemical mechanisms.5 Reproduced from ref. 5.  
  
1.3 Animal models 
Animal models, exemplified by rodents, dogs and monkeys, provide greater physiological 
relevance compared to traditional 2D cell cultures. Consequently they have been widely 
implemented to investigate the underlying cellular mechanisms of human physiology and 
have become the standard procedure of drug screening prior to clinical trials. However, 
animal models are expensive, time-consuming and ethically controversial.6 Furthermore, it is 
difficult to independently control experimental variables in animal models and their clinical 
translatability has been questioned largely due to the species difference between animals 
and humans.7 Approximately only 10% of the drug candidates entering the clinical trial reach 
the final approval stage and enter the market.8 Therefore, in vitro 3D cell culture models 
capturing the complexity of in vivo tissues and organs are emerging as a bridge between 
traditional 2D cell cultures and in vivo animal models, and have gained ever increasing 
attention for their use in a variety of biomedical applications such as drug development and 
toxicology.1 
 
1.4 Conventional 3D cell culture models 
Several conventional 3D cell culture models have been developed and they can generally 
be grouped into two categories: 1) scaffold-free models, exemplified by cell spheroid 
cultures (Figure 1.3A), and 2) scaffold-based models, exemplified by porous scaffolds with 
either simultaneous cell encapsulation or post-fabrication cell seeding (Figure 1.3B). 
 
 
Figure 1.3 A schematic diagram of conventional 3D cell culture models: scaffold-free (A)9 and scaffold-
based models (B)10. Adapted from ref. 9 (A) and ref. 10 (B). 
 
1.4.1 Scaffold-free models 
Cell spheroids are simple 3D culture models and can be generated by several techniques 
such as hanging drop, rotating culture and concave plates with non-adhesive surface coating. 
Spheroid 3D 
culture
Porous scaffold 
3D culture
A B
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The formation is based on the tendency of adherent cells to aggregate. As a result, spheroids 
as compact cell aggregates have found many uses especially in modeling solid tumor.1 
However, it is generally challenging to well control the size of formed cell spheroids. Also, 
when spheroids grow beyond a certain size, the diffusion of oxygen and nutrients becomes 
limited and subsequently leads to necrosis in the spheroid core.11 Most cells in vivo are 
supplied with oxygen and nutrients by an intricate vascular system composed of larger blood 
vessels that are subdivided into small capillaries. The adoption of such vascular system is due 
to the fact that diffusion only becomes a significant way of mass transport in the short 
length scale. Unlike convection in which the mass transport is linearly dependent on time if 
the volumetric flow rate is constant, diffusion distance is proportional to the square root of 
time according to the Einstein-Smoluchowski relation:  
 
𝑑𝑑 = √2𝐷𝐷𝐷𝐷 (in one dimension) 
 
where 𝑑𝑑 is the linear distance a particle has moved from its initial position in a time 𝐷𝐷, and 𝐷𝐷 
is the diffusion coefficient of the particle.12 Consequently, although diffusion occurs 
continuously, it is an extreme slow process over a large length scale. For example, oxygen in 
water takes about 5 min to diffuse 1 mm  (𝐷𝐷 = 2 × 10-9 m2/s)13, but only 2 sec to diffuse 100 
µm. Hence, cells in vivo are supplied with oxygen and nutrients through pervasive convective 
blood flows followed by local diffusion. Also, oxygen is being consumed by cells as it diffuses, 
thereby creating a maximum distance between cells and their closest capillaries where the 
diffusion is fast enough to compensate for the consumption. Such distance depends on 
various parameters including cell density and consumption rate. In native tissues, this 
maximum distance is typically a few hundred micrometers, although it may be much smaller 
in highly metabolically active tissues like heart muscles (Figure 1.4).14 Studies have shown 
that under appropriate culture conditions vascular endothelial cells can self-assemble to 
form new microvascular networks, a process called vasculogenesis.2,15 However, such 
spontaneous process occurs too slowly to supply the cells with adequate oxygen and 
nutrients during the time needed for a mature network to form.16 Therefore a general 
strategy to embed artificial vascular-like networks within cell culture models is in great 
demand. 
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Figure 1.4 A schematic diagram of diffusion and transport processes in vascularized tissues in vivo.14 
Reproduced from ref. 14. 
 
1.4.2 Scaffold-based models 
The use of a scaffold becomes more necessary as the size and complexity of a 3D model 
increases.1 Materials used for scaffolds can be divided into four groups: metals, ceramics, 
polymers and their composites.4 Among them, polymeric materials are the most widely used 
due to their great flexibility in controlling both their mechanical and chemical properties. 
 
1.4.2.1 Porous scaffolds with simultaneous cell encapsulation 
Porous scaffolds with simultaneous cell encapsulation are mostly restricted to hydrogel 
materials, which are polymeric crosslinked networks with high water content and 
recapitulate many physical and chemical properties of ECM.17 A hydrogel pre-polymer 
aqueous solution is mixed with a cell suspension and then quickly gelled through physical 
or/and chemical crosslinking mechanisms (Figure 1.5). Chemically crosslinked hydrogels are 
formed through covalent networks and therefore cannot dissolve in water without breakage 
of covalent bonds, while physical hydrogels are formed by dynamic and reversible networks 
based on non-covalent interactions such as hydrogen bond, hydrophobic and electrostatic 
interaction.18 As for polymers used for hydrogels, they are typically grouped into naturally 
derived (from living sources) and synthetic polymers.1 Naturally derived polymers, such as 
collagen and gelatin, generally mimic the native in vivo ECM composition better than 
synthetic polymers and possess many intrinsic biological cues for directing multiple cellular 
behaviors such as cell adhesion and migration.19 However, they often suffer from poor 
mechanical properties and batch-to-batch variations.20 On the other hand, synthetic 
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polymers, such as poly(ethylene glycol) (PEG), can be readily tailored to accommodate a 
range of physical and chemical requirements based on the specific application by controlling 
their chemical compositions, molecular weight, crosslinking density and so on. However, due 
to their general bio-inactivity, post modifications are usually required to render them 
adequate biofunctionality. For instance, conjugating PEG polymers with cell adhesive 
peptide sequences like arginine-glycine-aspartate (RGD) motif is a commonly used strategy 
to promote cell adhesion and compatibility for bioinert polymers.19 
 
 
Figure 1.5 A schematic diagram of representative mechanisms for hydrogel formation.21 Reproduced 
from ref. 21. 
 
Cell-encapsulated hydrogels have been extensively used as 3D in vitro models because 
they provide cells with their native 3D environment as well as cell-ECM interactions. 
Therefore distinct differences in cellular behaviors including morphogenesis, migration and 
differentiation have been observed compared to conventional 2D cultures. For example, 
breast epithelial cells cultured within 3D hydrogels formed an acinus structure possessing a 
cellular morphology similar to an in vivo structure that was never observed in 2D culture.22 
The high water content in hydrogels, which contains soluble nutrients and oxygen, can 
initially maintain cellular activity. However, the low solubility and slow diffusion of oxygen in 
water will eventually prevent sufficient oxygen supply, and meanwhile those random 
submicron-sized porous structures formed during the gelling process prohibits sufficient 
convective flow within hydrogels. Therefore adequate cell viability can only be maintained in 
7 
 
a limited thickness.4 Cells embedded deep within hydrogels cannot survive for long due to 
insufficient supply of oxygen and nutrients. 
 
1.4.2.2 Porous scaffolds with post-fabrication cell seeding 
As an alternative to hydrogel encapsulation, cells can also be seeded onto scaffolds after 
fabrication. Since cells are not involved during fabrication process, there is more flexibility in 
choosing materials and manufacturing techniques. A wide range of polymers can be used to 
construct porous scaffolds by conventional manufacturing techniques such as freeze-drying, 
gas foaming, solvent casting and particulate leaching.4 The usually formed random micro-
sized porous structures allow for diffusional mass transport as well as cell seeding. 
Cell-seeded porous scaffolds have found many uses especially in tissue engineering. 
Specifically, osteoblast-seeded porous scaffolds composed of biodegradable poly(lactic-co-
glycolic acid) (PLGA) and bioceramics (hydroxyapatite, HA) are widely used for bone tissue 
engineering. The biodegradable scaffolds provide temporal structural support for cells and 
are gradually degraded and subsequently replaced by newly formed bone tissues after 
implantation.23 However, it is very difficult to control the microscale structural 
characteristics of such porous scaffolds fabricated by those conventional techniques, 
including porosity, pore interconnectivity, pore size and geometry, and pore-size distribution, 
which are closely related to scaffold performance such as mass transport, cell distribution 
and growth.4 Despite the generally larger pore size in such porous scaffolds compared to 
hydrogels, mass transport via passive diffusion still will be limited and cell distribution is 
often limited to the area close to the scaffold surface.4 
 
1.4.3 Limitations of conventional 3D cell culture models 
Despite the great contributions made by those conventional 3D cell culture models, 
there are still some major drawbacks.10,24 
Firstly, they generally lack an adequate vascularization strategy to ensure sufficient 
supply of nutrients and oxygen throughout the whole model. Therefore, sufficient cell 
viability can only be maintained within a limited 3D depth. As a result, vascularization in full 
3D remains the key challenge in maintaining healthy cell cultures at a clinically relevant 
scale.14   
Secondly, for scaffold-based models it is challenging to control structural characteristics 
of scaffolds due to their conventional manufacturing techniques. 
Thirdly, they generally represent static culture conditions and therefore lack the ability 
to mimic the biochemically dynamic characteristics of in vivo systems. Although bioreactors 
commonly composed of a spinning or rotating container have been used to accommodate 
conventional 3D cell cultures and subsequently to facilitate nutrient supply and control over 
environmental conditions, their macroscale nature usually produces poorly defined fluidic 
dynamics.1,25,26  
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Consequently, microfluidic and 3D printing-based cell culture models have been 
developed to address the above shortcomings.   
       
1.5 Planar microfluidic cell culture models 
Microfluidic devices, where fluids can be precisely manipulated at microscale, are built 
with technologies first developed by the semiconductor industry.27 Basically, microfluidic cell 
culture models integrate microfluidics with those conventional 2D or 3D culture models. 
Cells can be cultured in microfluidic devices as a monolayer or as 3D modules such as 
spheroids and cell-encapsulated hydrogels. The major advantage of microfluidic cell culture 
over conventional cell cultures lies in its ability to manipulate fluids and its compartmental 
nature. However, due to their planar fabrication process, currently most of microfluidic 
devices feature 2D microfluidic networks. 
 
1.5.1 Fabrication of planar microfluidic devices 
Microfluidic devices used in research are mostly engineered by molding approaches 
based on polydimethylsiloxane (PDMS) due to a long list of key PDMS properties including 
biocompatibility, optical transparency, gas permeability and so on.28,29 The typical fabrication 
process consists of photolithography, replication and bonding (Figure 1.6). A silicon wafer is 
first spin coated with a thin film of photosensitive material (photoresist) and then exposed 
to UV light through a photomask containing defined micropatterns. Afterwards UV-exposed 
areas become either soluble or insoluble in a developer solution (a process termed 
development). Then pre-polymer of PDMS is cast against the silicon mold with patterned 
photoresist to generate a PDMS substrate that replicates the topography of the mold. Finally 
a PDMS substrate containing microchannel features is bonded with a blank PDMS slab or a 
cover glass to create a microfluidic device, where inlets and outlets can be made through 
punched holes. 
 
Figure 1.6 A schematic diagram showing the fabrication steps of PDMS microfluidic devices: mold 
fabrication based on photolithography (A) and replication/bonding process (B).30 Adapted from ref. 30. 
A
B
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1.5.2 The unique physical features that the microscale provides     
Due to the submillimeter length scale usually adopted in microfluidics, liquid flow is 
almost always laminar flow in microfluidic devices, allowing for highly predictable fluid 
dynamics, such as well controlled shear stress and diffusional rather than convective mixing 
among multiple laminar streams (Figure 1.7A).27 As a result, highly controlled chemical 
gradients can be generated by laminar flow splitting and mixing in microfluidic channels, 
which has found use in many applications, such as high throughput drug screening and 
chemotaxis (Figure 1.7B).31 
Similarly, compartmentalization can also be achieved by manipulation of laminar flows. 
For example, multiple hydrogel precursor solutions containing cells can be co-injected into 
“Y” shaped channels and subsequently gelled, resulting in separate but adjacent hydrogel 
compartments (Figure 1.7C).32 Alternatively, physical confining structures, such as 
micropillar arrays (Figure 1.7D) or porous membranes (Figure 1.7E), are widely utilized to 
realize compartmentalization in microfluidic devices.33 
 
 
Figure 1.7 A) Yellow and green dyed solutions were pumped into Y-shaped PDMS microchannels by 
passive pumping to form parallel laminar streams.32 Scale bar represents 6 mm. B) A schematic 
diagram of microfluidic gradient generation. Green color indicates the spatial distribution of a 
potential soluble factor of interest in a microfluidic device.34 C) A schematic diagram of loading and 
compartmentalization of cell-encapsulated hydrogels in a microfluidic device.32 Adapted from ref. 32 
(A,C) and ref. 34 (B). D) A schematic diagram of an array of micropillars separating a single microfluidic 
channel into three compartments: a central cell culture compartment and two side media perfusion 
compartments. E) A schematic diagram of a microfluidic channel composed of upper and lower 
chambers sandwiching a porous membrane.   
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1.5.3 “Organs-on-chips”            
The combination of laminar flow manipulation and compartmentalization enables 
spatiotemporal control over arrangements of multiple cell types, delivery of different soluble 
factors and physicochemical communications between differentiated environments in 
microfluidic cell cultures, which is very difficult, if not impossible, to achieve in conventional 
culture models.35 Consequently, the emerging field of “organs-on-chips” have been 
continuously developed and shown to mimic important aspects of the biochemically 
dynamic characteristics in vivo. This approach has made it possible to engineer models of 
brain,36,37 nerve,38,39 heart,40,41 kidney,42,43 liver,44–51 blood vessels,52–57 breast,32,58,59 lung,60 
gut61 and so on (Figure 1.8A-C).62,63 As a step forward, “human/body-on-a-chip”, where 
different cell types representing different organs are cultured in a fluidically-linked fashion 
within a single chip, has been developed to mimic and investigate organ-organ interactions 
(Figure 1.8D).64,65 A microfluidic chip with cultures of multiple cell types representing the 
liver, tumor and marrow, was used to test the cytotoxic effect of Tegafur, a well-studied oral 
prodrug of an anti-cancer drug, 5-fluorouracil, and the results were consistent with 
previously published clinical test results. Although still in the conceptual phase, 
“human/body-on-a-chip” demonstrates the potential of such approach to test metabolism-
dependent toxicity of drugs and subsequently to partially replace animal models for pre-
clinical trials.64 
 
 
Figure 1.8 A) A schematic diagram of a “lung-on-a-chip” device using compartmentalized PDMS 
microchannels to form an alveolar-capillary barrier on a porous PDMS membrane coated with ECM. 
A B
C D
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By applying vacuum to the side chambers and subsequently causing mechanical stretching of the 
membrane, the device recreates physiological breathing movements of lungs.60 B) A schematic 
diagram illustrating the glomerular filtration barrier in a kidney composed of glomerular endothelial 
cells, podocytes and a basement membrane that is selectively permeable to small molecules and 
water, as well as the design of a “glomerulus-on-a-chip” device composed of capillary channels, gel 
channels and collection channels, representing the capillary lumen, the glomerular basement 
membrane and Bowman’s capsule in glomerular microenvironment, respectively. The crescent 
microstructures were used to capture the glomerular microtissues.43 C) A schematic diagram of a 
“microvessel-on-a-chip” device reconstituting the formation and expansion of microvascular networks 
in response to pro-angiogenic factors (fibroblast-secreted factors from fibroblast channels) and 
interstitial flow (between two media channels).66 D) A schematic diagram of the “human/body-on-a-
chip” concept. Cell cultures of different cell types representing different organs are integrated into a 
single device and linked by a fluidic circulatory system in a physiologically relevant manner to model 
complex organ-organ interactions, which can find many uses such as in systematically evaluating drug 
efficacy and toxicity.29 Adapted from ref. 60 (A), ref. 43 (B), ref. 66 (C) and ref. 29 (D).           
 
1.5.4 Limitations of planar microfluidic cell culture models      
Despite various advantages that microfluidic cell culture models provide for better 
mimicking the dynamic characteristics of in vivo conditions, there are still many limitations 
that need to be addressed. 
Firstly, the fabrication process of PDMS microfluidic devices usually involves substantial 
labor due to multiple non-automated steps, and requires sophisticated equipment such as 
clean room facilities (for photolithography), which is not easily accessible to general users. 
Such manufacturing hurdles make PDMS devices difficult to disseminate outside of the 
microfluidics community.28 For example, despite the fact that microfluidic technologies are 
uniquely qualified for performing chemotaxis assays due to highly controlled fluidic 
dynamics at this scale, none of them has been routinely adopted in biological research and 
traditional methods such as “Transwell” assay developed in 1962 are still predominantly 
used by researchers for chemotaxis studies.27 
Secondly, PDMS microfluidic devices usually possess planar architectures due to the 
nature of their fabrication process. Limited 3D complexity can be achieved by stacking a 
series of patterned PDMS slabs, however, it is a tedious process where different layers must 
be carefully aligned and sealed (Figure 1.9).67,68 Although microfluidic devices can provide 
flows supplying oxygen and nutrients, which to some extent mimic native vascular networks, 
their planar configurations still limit their capability to fulfill vascularization in 3D. Instead, 
cellular components in microfluidic devices are either directly exposed to flow inside 
microchannels (which is not desired for most of cells in vivo except for endothelial cells) or 
flanked by flow in adjacent channels, while most in vivo tissues are perfused through an 
independent pervasive vascular network. 
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Figure 1.9 A) Stacking of 2D patterned PDMS slabs.68 Adapted from ref. 68. 
 
Thirdly, despite various advantages of using PDMS in microfluidic devices, it also 
possesses some major disadvantages. PDMS permits diffusion of compounds in vapor phase 
but not in the liquid phase.69 Consequently, cells can only be cultured on PDMS but not 
within and extra structural elements such as micropillars or porous membranes have to be 
included to realize mass transport of soluble factors between different compartments. 
Furthermore, PDMS has been reported to deplete the transported media of low polarity 
compounds by absorption, which can be problematic for many applications.69 As a result, 
other materials, such as thermoplastics,70,71 thermosets,72 and hydrogels,73–78 have been 
reported to manufacture PDMS-free microfluidic devices. Among them, microfluidic devices 
made of hydrogels are of particular interest due to their ability to recapitulate the properties 
of ECM, however, they are also often fabricated based on molding and replication process, 
which results in limited 3D complexity (Figure 1.10) and subsequently calls for new 
approaches to manufacturing true 3D hydrogel microfluidic devices. 
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Figure 1.10 A) A schematic diagram of fabrication of microfluidic collagen gels using sacrificial gelatin 
molds and overlaid phase-contrast and fluorescence images (top view) of a hexagonal channel 
network within a matrix of collagen and perfused with fluorescent microbeads.75 Insert is an image of 
a cross-section of a collagen channel. Scale bar represents 200 µm. B) A schematic diagram of 
fabrication of agarose microfluidic devices with or without embedded cells and phase contrast images 
(top and cross-sectional views) of a bifurcated channel in agarose hydrogel.76 Adapted from ref. 75 (A) 
and ref. 76 (B). 
 
Fortunately, the advent of 3D printing techniques offers new opportunities for 
addressing the abovementioned obstacles and producing next-generation in vitro 3D cell 
culture models. 
        
1.6 3D printing based cell culture models 
3D printing, or additive manufacturing has emerged as a versatile approach to 
constructing 3D objects. Unlike most conventional manufacturing techniques which remove 
material from a bulk piece of material such as milling and drilling, additive manufacturing 
works on adding materials in small volumes at a time or following a layer-by-layer fashion. 
3D printing based cell culture models basically integrate conventional culture models with a 
computer-aided fabrication process that transforms digital designs into 3D objects without 
masks or molds and thus allows for precise control over both external (macroscale) and 
internal (microscale) structures of the models. Such automated fabrication process also 
A
B
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drives the design and innovation cycle. A new idea of design can be easily implemented by 
computer-aided design (CAD) that is accessible to a larger audience, while in case of 
conventional planar microfluidics each new design requires fabrication of a new photomask, 
which is time consuming and restricted to well-trained personnel.  
Conventional culture models such as cell spheroids and cell-laden hydrogels are 
commonly used as modules to create 3D spatially defined constructs by 3D printing. 
Therefore, many materials used for conventional culture models can often be used for 3D 
printing as well.  
As mentioned before, compared to conventional culture models, the key advantage of 
microfluidic culture models is the spatiotemporal control over model elements, such as 
spatial arrangement of different cell types, dynamic control of soluble factors including 
chemical gradients, nutrients and oxygen supply. However, the general planar nature of 
current microfluidic devices limits their further use as true 3D culture models at clinically 
relevant scale. 3D printing has the potential to achieve spatiotemporal control over model 
elements in a full 3D manner. There are many existing 3D printing techniques based on 
various mechanisms and none of them has complete superiority over others.  
Regardless of the applications of constructed culture models, either as clinically useful 
replacements for damaged tissues/organs or as in vitro models for scientific studies such as 
drug development and in vitro disease modeling, vascularization in 3D is essential for 
maintaining healthy cultures. Since the construction of microfluidic channel networks is not 
inherently enabled by all 3D printing techniques, an overview of different 3D printing 
techniques will be given in the following sections while focus will be on those techniques 
that are most relevant for creating 3D models with embedded fluidic networks as 
vasculature.  
Researchers have categorized different printing techniques based on materials, 
solidifying mechanism, machinery, etc. In this thesis, different techniques are grouped 
according to the form in which each technique delivers the material: droplet-based, powder-
based, extrusion-based and stereolithography. 
 
1.6.1 Droplet-based printing 
Droplet-based printing, such as inkjet printing and laser-assisted printing, delivers 
materials in the form of droplets using various energy sources (thermal, electric, laser beam, 
acoustic or pneumatic mechanisms) onto a substrate (Figure 1.11A).79 It offers great 
advantages such as simplicity and precise control on deposition of biomaterials with or 
without cells.79 However, materials of low viscosity are usually used for inkjet printing due to 
the potential clogging of printhead nozzles and therefore when a dispensed droplet hits the 
substrate it tends to spread over, which makes it difficult to sustain the printed 3D 
structures.80,81 Although laser-assisted droplet-based printing can work with high viscosity 
liquids due to its nozzle-free approach, it suffers from high cost and bulky instrumentation.9 
Overall, droplet-based printing techniques have limited 3D capabilities (Figure 1.11B,C). 
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Figure 1.11 A) A schematic diagram of droplet-based printing techniques. Thermal inkjet printers 
electrically heat the printhead nozzle to produce air-pressure pulses to form droplets, whereas 
acoustic printers use pulses formed by piezoelectric or ultrasound pressure. Laser-assisted printers 
use lasers focused on an absorbing substrate to generate pressures that propel materials onto a 
collector substrate.82 B) Microscopic top views of a complete 3D multi-cell construct using inkjet 
printing. Three different types of cell were labeled with three different dyes.83 C) Seven alternating 
color-layers of red and green stained cells printed by laser-assisted printing viewed in cross-section.84 
Scale bar represents 500 µm. Adapted from ref. 82 (A), ref. 83 (B) and ref. 84 (C). 
 
1.6.2 Powder-based printing 
Powder-based printing works on the fusion of powders, which can be induced by laser 
sintering or a liquid binder that bonds adjacent powder particles together. The general 
printing process can be described in the following steps (Figure 1.12A): 1) the powder supply 
platform is lifted and the fabrication platform is lowered one layer; 2) the roller spreads the 
powder into a thin layer; 3) a printhead nozzle that inkjets a liquid binder (similar to droplet-
based printing) or a high-power laser scanning system selectively fuses powder particles 
together based on a computer-aided design (CAD) pattern; 4) cycling the above steps 
generates 3D structures.79,85 Since the non-bonded powders in each layer serve as structural 
supports, arbitrary 3D geometries can be created by powder-based printing. However, the 
resolution of powder-based printing is largely dependent on the powder particle size and it 
Inkjet printing Laser-assisted printing
Droplet-based printingA
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is very difficult to completely remove excess powders from small cavities, which makes it 
unsuitable for manufacturing microfluidic channel networks (Figure 1.12B).28 
 
 
Figure 1.12 A) A schematic diagram of powder-based printing technique.85 B) Top view of a 3D 
scaffold fabricated by powder-based printer with an inkjet printhead.86 Adapted from ref. 85 (A) and 
ref. 86 (B). 
 
1.6.3 Extrusion-based printing 
Extrusion-based printing is similar to droplet-based printing. Instead of depositing a 
single droplet, extrusion-based printing can dispense uninterrupted cylindrical filaments of 
viscous liquids by applying a continuous force (Figure 1.13A).81 Because of the continuous 
deposition of filaments, extrusion-based printing provides better structural integrity during 
rapid fabrication compared to droplet-based printing. However, it is unsuitable for printing 
elements of dots.87 
A wide range of materials can be used for extrusion-based printing. The two most 
commonly used are thermoplastics and shear-thinning hydrogels. Extrusion printing of 
thermoplastics is usually termed fused deposition modeling (FDM), where thermoplastic 
filaments are heated to their molten state, extruded from a printhead nozzle and instantly 
solidified onto a cool substrate without any additional crosslinking requirement. Degradable 
biomaterials such as poly(caprolactone) (PCL) and poly(lactic acid) (PLA) have been printed 
using FDM for hard tissue engineering applications (Figure 1.13B).79 However, due to the 
high temperature usually adopted in FDM, this technique is not cell compatible and 
therefore it is often used to create scaffolds that can be seeded with cells post-fabrication or 
molds that can be cast against using cell-laden biomaterials. 
Hydrogels possessing shear-thinning behavior can be printed without elevated 
temperature. When they are exposed to shear stress passing through the printhead nozzles, 
the resultant decreased viscosity makes them behave like liquid and hence become 
extrudable. Once extruded and upon removal of shear stress, the increased viscosity enables 
them to stay in shape. Due to its mild operating condition, cells and biomaterials can be 
Inkjet printhead or laserRoller
Powder bed
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simultaneously printed by simply loading cells into hydrogels, a process usually termed 
bioprinting.9,10,19,79,82,88 Furthermore, by implementing multiple printhead nozzles, different 
types of cells and biomaterials can be spatially deposited at desired positions (Figure 1.13C). 
Such versatility makes extrusion-based printing currently the most widely used approach for 
bioprinting.10 
 
 
Figure 1.13 A) A schematic diagram of extrusion-based printing techniques.81 B) A PLA scaffold printed 
by fused deposition modeling.89 Scale bar represents 5 mm. C) A schematic of diagram of a multi-
printhead extrusion printer capable of printing different biomaterials as well as different cell types 
(left) and an actual printed construct (right) using this approach composed of a thermal plastic 
material (PCL) and two types of alginate hydrogels stained with different fluorescent beads.90 Scale 
bar represents 2 mm. Adapted from ref. 81 (A), ref. 89 (B) and ref. 90 (C). 
 
Although extrusion-based printing provides better structural integrity than droplet-
based printing, an additional crosslinking/hardening process is usually required because 
extruded materials tend to fold or collapse under their own weight.91 Hence, direct extrusion 
printing of overhanging structures is still challenging and so far most 3D constructs 
demonstrated in extrusion printing have been rectilinear lattice architectures with limited 
topological complexity. This limitation has recently been overcome by extruding material 
into a support bath with particular rheological properties (Figure 1.14A).92–96 Printhead 
nozzles can move freely within the bath while deposited materials stay in place upon 
extrusion, thus leading to the construction of highly intricate architectures without any 
support structures (Figure 1.14B). However, upon the removal of support bath, it is difficult 
Extrusion-based printingA B
C
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to handle the remaining free-stranding structures that are usually composed of highly 
compliant materials such as hydrogels and therefore this technique has found limited use 
and applications so far other than the demonstration of constructing complex geometries. 
 
 
Figure 1.14 A) A schematic diagram of extrusion printing in a support bath.92 B) A thin-shell model 
octopus made of polyvinyl alcohol (PVA) hydrogel printed in a granular gel bath.95 C) Side and top 
views of a continuous network of hollow vessels made of PVA hydrogel printed in a granular gel bath 
(inserts: confocal microscopy cross sections).95 Adapted from ref. 92 (A) and ref. 95 (B,C). 
 
Construction of fluidic networks is not inherently enabled by extrusion-based printing. 
However, with recent development extrusion-based printing has been used in printing 
vascular-like networks supporting thick tissue constructs either through direct or indirect 
approaches.  
By applying a support bath (as previously mentioned) or a coaxial printhead nozzle 
configuration, hollow tubular structures can be directly printed using extrusion-based 
printing. Highly branched channel networks such as support-free arterial trees have been 
printed by extrusion printing in a support bath (Figure 1.14C).95 Despite the intricate 
architectures, such approach can usually only print relatively large diameter channels (Ø > 
500 µm) at comparatively low speeds, and has not yet been shown to produce directly 
perfusable constructs due to the difficulty in handling printed structures after the removal of 
support bath.92,93,95  
Extrusion printing in support bathA B
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Alternatively, a coaxial extrusion configuration has been proposed to produce hollow 
tubular structures mimicking the blood vessels by delivering a pre-polymer solution such as 
aqueous alginate solutions in the sheath flow and a crosslinking solution such as calcium 
chloride in the core, where in situ crosslinking of the pre-polymer solution through the 
diffusion of crosslinkers occur upon extrusion to obtain hollow tubular structures (Figure 
1.15A).97–111 Coaxial extrusion configuration has been almost exclusively applied to 
alginate/calcium hydrogels. Cells can be directly embedded in tubular structures by using 
cell-laden alginate (Figure 1.15B)103,106,107 or later included by embedding printed hollow 
tubes in other cell-laden matrices (Figure 1.15C).97,100 However, coaxial extrusion printing 
cannot print bifurcated channel structures since it has inherent limitations in connecting 
newly printed hollow tubular structures to already printed ones. 
 
Figure 1.15 A) A schematic diagram of coaxial extrusion configuration.98 B) Confocal live (green)/dead 
(red) staining of human umbilical vein endothelial cells (HUVECs) encapsulated in alginate/gelatin 
hydrogel tubular structures printed using coaxial configuration.107 C) Alginate hollow tubes printed 
using coaxial configuration were embedded in bulk hydrogels.98 Arrow indicates medium flow 
direction. Adapted from ref. 98 (A,C) and ref. 107 (B). 
 
Fluidic channel networks can also be indirectly printed by extrusion-based printing when 
used in combination with sacrificial molding. Sacrificial filaments, such as carbohydrate 
glass,112 gelatin,113 agarose114 and fugitive inks of Pluronics,115–117 are first extrusion printed 
and later cast into cell-laden hydrogels (Figure 1.16). Upon removal of those sacrificial 
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materials, fluidic channel networks are formed and subsequent perfusion of channels can 
maintain long-term cell viability in 3D cell cultures that exceed 1 cm in thickness.116 
 
 
Figure 1.16 A) Sacrificial carbohydrate filaments were extrusion printed and then cast in a cell-laden 
fibrin hydrogel. The carbohydrate template was removed by dissolving it in culture medium. HUVECs 
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(red) were then seeded throughout the channel network by a single injection and fibroblasts (green) 
were encapsulated in fibrin gel.112 Scale bar represents 1 mm. B) Sacrificial Pluronics filaments were 
first extrusion printed and then cast in a gelatin/fibrin hydrogel. The template was liquefied at low 
temperature (4 oC) and removed by vacuum suction. Top and perspective views of a printed construct 
containing lattice channel networks were shown in the photographs.116 Scale bar represents 5 mm. C) 
Sacrificial agarose filaments were first extrusion printed and then cast in a gelatin methacrylate 
(GelMA) hydrogel. The template was removed by pulling or vacuum suction. The resultant channel 
networks were perfused with a fluorescent microbead suspension (pink).114 Scale bar represents 3 
mm. Adapted from ref. 112 (A), ref. 116 (B) and ref. 114 (C). 
 
Construction of fluidic channel networks using extrusion-based printing either with 
coaxial configuration or in combination with sacrificial molding represents a major step 
forward in constructing 3D hydrogel microfluidics for next-generation cell culture models. 
However, most fluidic channel networks generated by such approach lack sufficient 3D 
complexity, a common problem observed in extrusion-based printing as previously discussed. 
Furthermore, the formed channel networks are ultimately defined only by the hydrogels 
used for cell encapsulation, which are usually highly compliant materials based on natural 
polymers such as alginate, collagen and gelatin. Such materials are very well suited for 3D 
cell culture with in vivo-like mechanical properties and the possibility for cell-induced matrix 
remolding, but the resulting constructs’ high compliance and limited long-term structural 
fidelity and stability challenge their use as self-contained perfusable in vitro systems. 
 
1.6.4 Stereolithography 
1.6.4.1 The basics of stereolithography 
Stereolithography (SLA) is the technique used in this thesis and its working mechanism is 
fundamentally different from the techniques introduced previously. Stereolithography is 
considered to be the first commercialized 3D printing technique, developed by 3D systems in 
1986.118 The manufacturing of 3D objects by stereolithography is based on the spatially 
controlled solidification of a liquid resin by photopolymerization following a layer-by-layer 
fashion. The originally proposed SLA apparatus is composed of: 1) a reservoir/vat to 
accommodate a liquid photocurable resin; 2) a light source and a system that subsequently 
controls the XY-movement of the light beam; 3) and finally a fabrication platform that 
printed structures can adhere to and that permits movement in the vertical direction and 
thus layer-by-layer fabrication (Figure 1.17A).85 Before fabrication, a computer-aided design 
(CAD) file of a 3D object is sliced to generate a series of planar patterns and the spacing 
between each neighboring planar pattern is defined as slicing thickness (usually in the range 
of 25-100 µm) (Figure 1.17B).119 Smaller slicing thickness improves structural fidelity but also 
increases fabrication time by having more slices. The patterned light defined by the CAD 
design is first irradiated on the photosensitive resin surface to create a solid phase of the 
material. The first layer of polymerized materials is adhered to the fabrication platform, 
which provides support for structures as they are fabricated. The platform is then moved a 
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defined step height usually equivalent to the slicing thickness, allowing for polymerization of 
the subsequent layer (Figure 1.17A). This process is repeated until a 3D structure is 
completed.120 
 
Figure 1.17 A) A schematic diagram of two different setups of SLA apparatus: bottom-up and top-
down.85 Adapted from ref. 85 (A). B) A schematic diagram of slicing a pyramid 3D CAD model into 3 
layers.  
 
In case of traditional SLA, each feature in a patterned layer is cured by sequential laser 
scanning (Figure 1.17A, left). However, an alternative form of SLA using digital light 
projection (DLP) has been recently developed and gained ever increasing interest to cure an 
entire layer at once (Figure 1.17A, right). This approach was first demonstrated with a liquid 
crystal display (LCD), but is now evolved into an inexpensive, commercially available 
projection system based om a digital micromirror device (DMD) functioning as dynamic 
pattern generator.121 Using a DLP, each patterned layer is sequentially projected onto the 
resin at once as a digital mask, which substantially reduces fabrication time compared to 
traditional laser scanning. 
Depending on whether polymerization occurs at the top or the bottom surface of the vat, 
there are generally two setups for SLA: bottom-up and top-down (Figure 1.17A).28,85,121 In a 
so-called bottom-up setup, the resin is polymerized at its topmost surface interfacing with 
Slicing thickness, usually 
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certain distance, termed the step height, for each new layer
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air and accordingly the fabrication platform is translated downwards into the vat after each 
layer is printed. Conversely, in a top-down setup, the resin is cured at the bottom surface of 
the vat. After each layer is printed, the fabrication platform suspended upside down above 
the vat is moved upwards to allow for printing of subsequent layer. Usually, a laser scanning 
system adopts the bottom-up setup while a DLP system adopts the top-down approach. 
Although the bottom-up set was developed earlier and is still widely used in SLA, the more 
recent top-down setup offers certain advantages: 1) object height is not limited by the vat 
depth, which usually leads to less resin consumption; 2) since the polymerization, usually 
radical polymerization in SLA, takes place away from the liquid-air interface, therefore 
oxygen inhibition is minimized compared to the bottom-up setup and the resin can be cured 
faster. However, in the top-down setup, separating every newly formed layer from the vat 
bottom subjects the structure to larger mechanical forces compared to the bottom-up setup, 
which can damage fragile and delicate features, and therefore a non-adhesive bottom is 
usually required to facilitate gentle separation. In this thesis, a DMD based projection SLA 
with the top-down setup is utilized. 
 
1.6.4.2 Resins used for stereolithography         
Resins used for SLA consist of two essential components: monomer and photoinitiator. 
Often, they also contain non-reactive substances such as a diluent/solvent to reduce resin 
viscosity and a photoabsorber to control light penetration depth. When a photoinitiator is 
activated by light, the resultant reactive species polymerize the monomers to form a solid 
crosslinked polymer network.122 It should be noted that usually the photoinitiator is 
activated by absorbing a single photon in the UV or near UV range. However, in certain 
circumstance, a suitable photoinitiator can absorb two photons simultaneously through the 
irradiation with near-infrared femtosecond laser pulses of about 800 nm, causing them to 
act as one photon of 400 nm with equivalent energy to UV or near UV range. Unlike single 
photon absorption which is a linear excitation process, the probability of two-photon 
absorption is proportional to the square of the laser intensity and therefore the absorption 
rate decreases steeply with distance from the focal plane when using high numerical 
aperture objectives.85,123 Such non-linear excitation process triggers polymerization only in 
the focal point while other regions remain unaffected. Subsequently, two-photon 
polymerization (2PP) inherently gives 3D capability through direct laser writing within a 
liquid matrix and it can achieve submicron resolution, a resolution basically no other 3D 
printing techniques can achieve. However, due to the fact that polymerization only occurs at 
the focal point, 2PP is an extremely slow process. In addition, 2PP requires expensive and 
sophisticated equipment, and therefore it is not widely adopted for practical uses. So far, 
only single photon absorption has been adopted for SLA. 
As different resins have different light absorption spectra, they have different light 
penetration depths thus different curing depths.121,122 Curing depth is the key characteristic 
of a resin formulation and hence very important for SLA process (Figure 1.18). The curing 
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depth should be slightly larger than the step height/slicing thickness adopted for the 
fabrication process so that mechanically stable structures can be printed through strong 
bonding between neighboring layers (unreacted functional groups in the preceding layer can 
polymerize with the subsequent layer).119 Curing depth should be well controlled so that 
light does not penetrate too deep into the preceding layer causing undesired features (light 
penetrates into and subsequently polymerizes the uncured resin). Specifically in case of 
printing fluidic channels, too large curing depth can cause overcuring of the channel ceiling 
into the channel volume, resulting in reduced vertical dimensions and sometimes even 
complete occlusion of the channel (Figure 1.18A). High photoinitiator concentration can be 
used to reduce curing depth by increasing the absorption of the resin, but also results in the 
formation of very brittle structures due to high crosslinking densities. Also, a high initiator 
concentration is not desired if the printed structures are intended for biomedical 
applications due to cytotoxicity of the initiator either on its own or its residues. Therefore, a 
non-reactive photoabsorber is commonly added to control light penetration depth, 
effectively restricting the polymerization to a thin layer. In addition to photoinitiator and 
photoabsorber, curing depth is also dependent on light dose and monomer concentration. 
Therefore, optimization of the resin formulation based on various parameters including 
monomer concentration, photoinitiator type and concentration, photoabsorber type and 
concentration and light dose, is crucial and far from trivial in order to fabricate constructs 
with both required structural stability and fidelity (especially in the vertical dimension). 
Resin optimization is one major part of this thesis. 
 
 
Figure 1.18 A,B) A schematic diagram shows how curing depth affects SLA printing. In (A), the resin 
contains no or too little photoabsorber so the light can penetrate way beyond the next targeted 
25 
 
pattern and subsequently polymerize the unreacted resin in the channel volume, resulting in the 
reduction of the vertical dimension of the channel. On the contrary, in (B), the resin contains too 
much photoabsorber, and therefore the curing depth is too little for the next printed layer to adhere 
to or form a strong bonding with the previous one, resulting in mechanically instable prints.   
 
Conventional SLA resins are based on multi-functional acrylates and epoxies that are 
usually diluted by organic solvents, which predominantly produce glassy, rigid and brittle 
structures due to highly crosslinked networks. Such conventional resins are commonly used 
for industrial applications, but they are not suitable for biomedical applications. Recently, 
more and more materials such as acrylate functionalized polyester, polyether and naturally 
derived polymer have been developed for SLA use, which opens avenues for more 
applications. However, the limited number of resins that are commercially available for SLA 
is still considered one of the main limitations of the technique.119 
 
1.6.4.3 Stereolithography in constructing cell culture models 
Compared to extrusion-based printing, SLA has the potential for 3D freeform printing at 
high spatial resolution and high fabrication speed. So far, SLA is mainly used to fabricate cell 
scaffolds with repetitive internal pore architectures such as woodpile, hexagonal or gyroid 
geometries for hard tissue engineering such as bones (Figure 1.19A-C).124–141 Unlike scaffolds 
fabricated using conventional techniques such as gas foaming, microscale structural 
characteristics including porosity, pore interconnectivity, pore size and geometry are well 
defined in SLA printed constructs, which allows researchers to study structure-property 
relations. Furthermore, medical images obtained from magnetic resonance imaging (MRI) or 
computed tomography (CT) scans can be used to create 3D models via CAD and then printed 
by SLA to create structures with patient-specific anatomically correct geometries (Figure 
1.19D).142 However, transport of oxygen and nutrients in such scaffolds is still only mediated 
by passive diffusion instead of perfusion by convective flow. 
 
 
Figure 1.19 A) Scanning electron microscopic (SEM) images (perspective and top vies) of a SLA printed 
scaffold with woodpile features using poly(propylene fumarate) (PPF).133 B) SEM images (perspective 
and top views) of a SLA printed PPF scaffold with hexagonal pores.126 Scale bars represent 600 (left) 
and 500 µm (right), respectively. C) A photographic image (perspective view) of a SLA printed scaffold 
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with gyroid architectures using polylactide and a SEM image (top view) of the same scaffold.129 Scale 
bar represents 500 µm. D) A schematic diagram of design and fabrication process of 3D SLA printed 
graft to treat a coarctation of the aorta. Images obtained from medical imaging such as MRI are used 
to create a CAD model and a customized vascular graft is then SLA printed using PPF.143 Adapted from 
ref. 133 (A), ref. 126 (B), ref. 129 (C) and ref. 143 (D). 
   
Unlike extrusion-based printing, embedding fluidic channel networks within 3D 
constructs is inherently enabled by SLA and so far SLA has been used to print simple 3D 
branched networks (Figure 1.20A)144 as well as to manufacture 3D microfluidic devices 
without cell culture components (Figure 1.20B).145,146 However, there have been very limited 
reports on construction of 3D structures with both embedded fluidic channel networks and 
cell culture units using SLA techniques.147 
 
 
Figure 1.20 A) Photographic images (perspective and side views) of a PEG SLA printed scaffold 
embedded with a bifurcated channel network.144 B) Photograph of a SLA printed laminar flow device. 
148 The insert is the 3D model design. Adapted from ref. 144 (A) and ref. 148 (B). 
 
1.6.4.4 Limitations of stereolithography 
Although stereolithography has the potential for constructing complex 3D structures 
with high resolution and high fabrication speed, the use of SLA for in vitro cell culture 
models is still in its infancy due to several limitations. 
Firstly, SLA is mostly restricted to the use of a single material, unlike extrusion-based 
printing where multiple materials can be easily deposited by simply implementing multiple 
printhead nozzles. To some extent, multi-material deposition can be achieved by manually 
switching to a new photopolymerizable resin between each layer fabrication.125,134,144,147,149–
151 However, such process is labor-intensive and therefore the structures fabricated by this 
approach have limited 3D complexity and limited number of layers. In addition, manual 
operation between each layer also diminishes the point of using SLA as an automated rapid 
prototyping technique. Hence, to realize full capacity of multi-material printing in SLA 
requires sophisticated chemistries to allow for independent polymerizations of different 
monomers induced by different photoinitiators. 
Secondly, although with optimized resin formulation cell encapsulation during 
fabrication with adequate cell viability has been achieved in SLA,138,144,147,149,152–155 the 
general toxicity of reactive species produced by photoinitiators requires the commonly 
adopted post-fabrication cell seeding strategy. In addition to the toxicity, cell settlement in 
A B
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liquid resin during fabrication also poses a limitation that leads to uneven cell distribution. 
Some density gradient adjusting agents have been used to match the buoyant density of the 
cells with the resin to keep them suspended during fabrication.138 However, such approach 
further complicates the process by requiring more optimizations. Furthermore, because SLA 
printed structures are mostly composed of irreversible chemically crosslinked polymer 
networks due to photopolymerization and therefore cannot be easily removed under mild 
and cell compatible conditions, SLA is usually not used in combination with sacrificial 
molding to create cell-laden structures with embedded fluidic channel networks. 
Thirdly, the shortage of suitable resins hinders SLA’s further applications towards 
constructing in vitro cell culture models. Since cells are usually post-fabrication seeded, 3D 
constructs with both embedded fluidic channel networks and cell culture compartments 
should be first created using SLA. However, currently most resins adopted for SLA are 
composed of rigid and non-diffusion-open materials. Because SLA cannot usually achieve a 
resolution that is seen in photolithography, microstructural elements (< 50 µm) such as 
micropillars cannot be easily printed to establish mass transport between culture 
compartments and fluidic channel networks,148 unlike the case in conventional planar 
microfluidic cell culture models. Therefore, a diffusion-open material is in great demand. 
Although hydrogels fulfill the requirements, their generally low stiffness makes it difficult for 
SLA to print structures with both structural complexity and required mechanical stability, 
especially in the case of a top-down setup where structures are subject to larger mechanical 
forces as previously discussed. Hence, development of resins that can generate cell 
compatible, diffusion-open and mechanically stable culture units will be crucial to 
constructing advanced in vitro cell culture models using SLA techniques. 
 
1.6.4.5 Summary 
The main advantages and disadvantages of both SLA and extrusion-based printing (the 
most widely used technique for bioprinting) in constructing cell culture models with 
embedded vascular-like channel networks are summarized in Table 1.1. Stereolithography is 
chosen for this project due to its superior manufacturability in terms of high resolution and 
reproducibility compared to extrusion-based printing, thereby aiming to bridge the gap 
between high biological relevance usually sought in academia and robust production process 
usually sought in industry. 
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 Advantages Disadvantages 
Extrusion-
based 
bioprinting 
• Capability of simultaneous 
deposition of multiple materials 
and cell types 
• A larger selection of materials 
that can be used 
• Limited resolution and limited 
control of structural elements (can 
only print filament but not dots) 
• The formed channel networks are 
usually maintained by the same 
materials used for cell encapsulation 
after the removal of sacrificial 
template, namely highly compliant 
hydrogels and therefore lack long-
term mechanical stability 
SLA 
• High resolution and 3D 
freeform printing capability 
• Direct embedding fluidic 
networks without sacrificial 
molding and flexibility of using 
different materials for vascularized 
constructs (mechanically stable) 
and cell encapsulation (compliant 
hydrogels) 
• Limited capability of deposition of 
multiple materials/cell types 
• Shortage of suitable resins for 
printing diffusion-open yet 
mechanically stable structures 
Table 1.1 A summary of main advantages and disadvantages of extrusion-based bioprinting and 
stereolithography. 
29 
 
Chapter 2: 
Hydrogel 3D microfluidics based on a modified commercial 
stereolithography printer 
Initial studies were conducted on a commercial stereolithography printer (Perfactory 
µicro, EnvisionTEC) that uses projection-based stereolithography adopting the top down 
setup and features a light source at 405 nm as well as a fixed step height of 25 µm (Figure 
2.1). Detailed information regarding the printer can be found in the experimental section. 
 
 
Figure 2.1 A photography of our commercial stereolithography printer from EnvisionTEC company 
containing three major components: DMD-based projector with 405 nm light source, a resin vat and 
fabrication platform. 
 
2.1 Choice of resin components 
An aqueous pre-polymer solution composed of monomer, namely poly(ethylene glycol) 
diacrylate (PEGDA, Mn 700 g mol-1), photoinitiator (lithium phenyl-2,4,6-
trimethylbenzoylphosphinate, LAP) and photoabsorber (quinoline yellow, QY) was employed 
for stereolithography. An aqueous resin is essential for perfusion structures since printed 
constructs will be eventually used in aqueous environment. Direct printing in aqueous 
solution minimizes structural changes caused by post-printing swelling. PEGDA (Figure 2.2C), 
a synthetic polymer, has commonly been used for cell encapsulation in biomedical studies 
due to its cell compatibility and non-fouling property. Cell encapsulation typically uses higher 
MW PEGDA (Mn > 2000 g mol-1) since the resulting more compliant hydrogels of lower cross-
linking density permit cells to proliferate and migrate.156–158 Other researchers have used 
DMD-based projector 
with 405 nm light source
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Fabrication platform
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undiluted highly crosslinked low MW PEGDA (Mn 250 g mol-1) to manufacture microfluidic 
devices that resist swelling and are impermeable to water, and consequently impermeable 
to water-soluble nutrients.145,146,148 Our aim is to manufacture the perfusion chip unit 
surrounding the encapsulated cells, and we consequently selected a medium MW PEGDA to 
produce mechanically stable, yet diffusion-open, compliant hydrogel constructs.159 In 
addition, PEGDA (Mn 700 g mol-1) is commercially available at a much cheaper price 
compared to its analogues with higher MW, which is cost-efficient for large scale production 
using SLA that usually requires high resin consumption. The commercial printer has a light 
source at the wavelength of 405 nm, while the majority of photoinitiators is activated by UV 
light and not water soluble.  A recently developed water soluble as well as cytocompatible 
photoinitiator, namely LAP, has been reported to absorb, albeit weakly, also in the visible 
range between 400 and 420 nm (Figure 2.2A).159,160 Thus it has been widely used for cell 
encapsulation in photopolymerizable hydrogels159,160 and is chosen as photoinitiator in this 
thesis. LAP has also been recently commercialized. QY, a commonly used food dye is 
selected in this thesis because of its high absorption around 405 nm (maximum absorption 
at 413 nm) (Figure 2.2B), excellent water solubility (in the form of its sulfonic acid sodium 
salt) and low cytotoxicity. The photoabsorber was used to limit the light penetration into the 
pre-polymer solution and thereby to achieve an optical Z resolution of the printer by 
matching its concentration to the printing process, as discussed previously. 
 
Figure 2.2 A) UV-Vis absorption spectrum of 200 µg/mL LAP in DI water in a quartz cuvette with 10 
mm light path. B) UV-Vis absorption spectrum of 12 µg/mL QY in DI water in a quartz cuvette with 10 
mm light path. C) A schematic diagram of radical polymerization of PEGDA to form hydrogel networks. 
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2.2 The effect of photoabsorber on resin curing depth 
Based on the previous work in the group on photo-patterning PEGDA hydrogels using 
LAP and the same light exposure unit from the printer as a standard visible light projector, 
200 mg/mL PEGDA, 5 mg/mL LAP and illumination times of 60 s were used as base 
experimental parameters for the remaining work.159 As discussed before, photoabsorber is 
essential for stereolithography to achieve optimal vertical resolution. Therefore different 
concentrations of QY were first tested for their effect on the curing depth. Resins composed 
of 200 mg/mL PEGDA, 5 mg/mL LAP, 10 µg/mL fluorescein o-acrylate and different QY 
concentrations were placed in a multi-well plate containing a pre-treated cover slip (with 
methacrylate-functional silane) at the bottom of each well and then exposed to a projected 
light pattern for 60, 90 or 120 s. The thickness of formed gels was characterized using 
confocal microscopy to obtain the curing depth. Acrylate-functional fluorescein was added 
for the purpose of visualization. Although the absorption of fluorescein around 400 nm is 
very low, the addition of 100 µg/mL acrylate-functional fluorescein was found to inhibit 
polymerization while 1 µg/mL was not sufficient for visualization. A concentration of 10 
µg/mL was then selected due to easy visualization and insignificant inhibitory effect on 
polymerization. The formed gels were chemically linked to the pre-treated cover slip due to 
coated methacrylate groups and thus can be easily handled for characterization. A grid 
pattern (for better contrast under the microscope) was projected to form pattern gels and 
the resultant gel thickness was measured using z-stack in confocal microscopy (Figure 
2.3A,B). As shown in Figure 2.3C, the gel thickness decreased with increasing QY 
concentration as expected. Moreover, as shown in Figure 2.3D, with the same QY 
concentration, the gel thickness slightly increased with enhanced exposure time and 
remained the same after 90 s exposure. Therefore, 0.8 mg/mL QY, which gave a curing depth 
of 40 µm under 60 s exposure, was chosen as a starting concentration for 3D printing test to 
match the step height of 25 µm so strong bonding between neighboring layers can be 
achieved. 
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Figure 2.3 A) A grid pattern design used for patterning PEGDA hydrogels. B) A representative 
fluorescence microscopic image of the patterned gels. C) The thickness of the formed PEGDA 
hydrogels with different QY concentrations at an exposure time of 60 s. D) The thickness of the 
formed PEGDA hydrogels with different exposure times at a QY concentration of 0.8 mg/mL. 
 
2.3 Modification of the commercial printer 
The original vat requiring at least 20 mL resin for each print was oversized for 
preliminary test and therefore a home-made vat was made using a commercial fused 
deposition printer (Makerbot) in order to reduce resin consumption. A 3D printed PLA plate, 
a transparent poly(methyl methacrylate) (PMMA) slab and a 3D printed PLA well-shaped 
resin container (Ø = 26 mm, depth of 5 mm) were assembled to make the home-made vat 
using double-sided adhesive tapes (Figure 2.4). Since the reduced resin container cannot 
accommodate the original fabrication platform, a home-made fabrication platform was also 
made by assembling a 3D printed PLA hanger, a PMMA cylinder (Ø = 10 mm, height of 5 mm) 
and a pre-treated cover slip (Ø = 20 mm, thickness between 130 and 160 µm) to which 
printed gels adhere to using double-sided adhesive tapes (Figure 2.4). With the home-made 
vat, only 2 mL resin was required for each print. The fabrication platform needs to make its 
initial approach towards the bottom of the vat until it is close enough for the first layer to 
adhere to the cover slip. This initial approach process has been calibrated by the 
manufacturer and cannot be changed. Therefore, in order to calibrate the same process with 
our modified vat and fabrication platform, the height of the assembled home-made 
200 µm500 µm
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fabrication platform was designed to be slightly smaller than the original platform, thus 
allowing for dimensional deviation stemming from the printing process. The optimal height 
was then calibrated by adjusting the number of adhesive tape layers (each glue layer about 
150 µm thick) between the hanger and the PMMA cylinder until a cover slip placed at the 
bottom of the vat can be picked up by the cylinder with one adhesive tape layer on the other 
side when the platform makes its initial approach and afterwards return to its home position. 
 
 
Figure 2.4 A photography of the modified commercial printer and a schematic diagram showing how 
the home-made vat and fabrication platform were built and assembled. 
 
2.4 Optimization of printing configurations 
2.4.1 The importance of a non-adhesive surface at the vat bottom 
As mentioned before, a resin composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 0.8 
mg/mL QY, as well as exposure time of 60 s for each layer was first selected for 3D printing 
test. A simple block design (5 mm × 5 mm × 1.5 mm) was implemented. However, the 
printing was unsuccessful. The majority of the structure was found in the vat instead of 
attached to the cover slip after printing. It was suspected that the structure broke during the 
printing due to the larger mechanical force the structure was subject to during the 
separation of each new layer from the bottom. Thus a non-adhesive fluorinated ethylene 
propylene (FEP) foil (130 µm thick) was applied to the vat bottom to facilitate smooth 
release of each printed new layer from the vat. Consequently a hydrogel block was 
successfully printed with nothing left in the vat after printing. Later, a tapered design was 
implemented to further test the printability (Figure 2.5A-C). Since the top square is larger 
than the bottom one, each subsequent layer has some overhanging structures that are more 
subject to mechanical forces. Such a tapered structure is not easy to print using other 3D 
printing techniques without any structural support such as extrusion-based printing. 
However, with the applied non-adhesive foil, the tapered structure was successfully printed 
and characterized by confocal microscopy. The same resin formulation and exposure time 
was adopted, except for the addition of 10 µg/mL acrylate fluorescein for visualization. As 
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shown in Figure 2.5D, the tapering angle matched well with the design. The same tapered 
structure was then printed with increasing QY concentrations and the highest QY 
concentration allowing for successful printing was found to be 1.2 mg/mL. Hence, QY 
concentration of 1.2 mg/mL was adopted for the remaining work so the optimal vertical 
resolution can be achieved with this resin formulation. 
 
Figure 2.5 A) A 3D design of a tapered structure (perspective view). B) The orthographic view (top) of 
the design in (A). C) The orthographic view (side) of the design in (A). D) An orthogonal confocal 
fluorescence image (side view) of the printed tapered structure using 200 mg/mL PEGDA, 5 mg/mL 
LAP, 0.8 mg/mL QY and exposure time of 60 s. 
 
2.4.2 The spatial printing resolution for microchannels 
Since the aim of this project is to print hydrogel constructs with fluidic networks, the 
spatial resolution of the printer setup for printing microchannels was then explored. The 
concept of stereolithographic printing resolution is not consistently considered in the 
literature where the reported achievable spatial resolution often refers to the level of detail 
of open-surface features instead of closed channel structures.148 The distinction between 
open and closed channels using stereolithography is important, since the structural fidelity 
of a closed rectangular channel largely depends on the light penetration depth into the pre-
polymer solution (Z resolution), as previously discussed, while that of an open channel 
mainly depends on XY resolution pre-determined by the light exposure units of the printer. 
Therefore, a more relevant resolution assessment of channel structures is the deviation of 
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the printed dimensions of a sealed perfusable channel from the design dimensions.146,148 A 
series of rectangular channels were printed and both their horizontal and vertical 
dimensions were subsequently characterized using optical microscopy, as shown in Figure 
2.6. Overall, the printed dimensions of microchannels matched the design ones well. The 
channels with 100 µm in vertical dimension were more poorly defined compared to the 
other channels, especially for 100 µm × 100 µm channel which was almost occluded. 
 
Figure 2.6 A) A representative 3D design of a block with microchannels of desired dimensions. B) 
Measured printed channel dimensions versus design dimensions (error bars show the standard 
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deviation, n = 3) from optical micrographs of cross-sections of a series of rectangular channels. The 
resin was composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 1.2 mg/mL QY. The exposure time for 
each layer was 60 s. C) Representative optical micrographs of cross-sections of a series of rectangular 
channels. 
 
Native vascular networks use circular channel geometries that lead to homogenous wall 
shear stress, in contrast to the variable wall shear stress in rectangular channels.161 
Therefore, we also evaluated printing of circular geometries of decreasing diameters using 
the same resin formulation. The resulting channel cross-sections were less well-defined 
compared to rectangular channels, as shown in Figure 2.7. The channels adopted elliptic 
geometry and the channel with 100 µm diameter was almost occluded, similar to what was 
observed in rectangular channels. 
 
 
Figure 2.7 Representative optical micrographs of cross-sections of a series of printed circular 
microchannels with decreasing diameters from 400 µm to 100 µm. The resin was composed of 200 
mg/mL PEGDA, 5 mg/mL LAP and 1.2 mg/mL QY. The exposure time for each layer was 60 s. 
 
2.4.3 The effect of PEGDA concentration on printing 
PEGDA concentration affects crosslinking density. Generally speaking, higher 
concentration leads to higher crosslinking density and thus produces stiffer hydrogels with 
better mechanical stability. However, higher crosslinking density also poses enhanced 
diffusion barrier for larger molecules such as proteins. Therefore, different PEGDA 
concentrations were tested for printing in order to determine the optimal PEGDA 
concentration that produces mechanical stable structures with the lowest crosslinking 
density as possible. Hydrogels constructs with rectangular microchannels were printed using 
100, 150, 200 and 250 mg/mL PEGDA. As shown in Figure 2.8, channels printed using 100 
and 150 mg/mL PEGDA were distorted compared to the ones printed using 200 and 250 
mg/mL. Although the highest concentration tested so far (250 mg/mL) produces the most 
well-defined channel structures, 200 mg/mL is still selected for the remaining work due to its 
lower crosslinking density and thus minimized diffusion barrier for large molecules. 
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Figure 2.8 Optical micrographs (top and side views) of printed hydrogel blocks with microchannels of 
various sizes. The resin was composed of 100, 150, 200 or 250 mg/mL PEGDA, 5 mg/mL LAP and 1.2 
mg/mL QY. The exposure time for each layer was 60 s. Scale bars represent 500 µm. 
 
2.5 Cell compatibility of the printed PEGDA hydrogel constructs 
Cell compatibility is a key characteristic of materials or constructs used for biomedical 
applications. Although all the resin components used in this thesis has shown to be cell 
compatible based on extensive previous studies,125,127,136,138,140,149,156–160,162–170 we investigated 
their combined effect on cell compatibility on SLA printed hydrogel sheets (Ø = 11 mm, 
thickness of 0.4 mm) (Figure 2.9A). An endothelial cell line (CRL-2922) was selected because 
ideally endothelial cells should line the synthetic vascular-like channel wall to regulate solute 
transport and facilitate homeostasis as in the in vivo situation.171 Prior to cell seeding, the 
surfaces of printed hydrogel sheets were coated with cell adhesive arginine-glycine-aspartic 
acid (RGD) peptides since pristine PEGDA hydrogels surfaces do not support cell attachment. 
Printed hydrogel sheets with unreacted acrylate groups on the surfaces were exposed to 
LAP-containing acrylated RGD peptide solution and subsequently to UV-A illumination. 
Top view Side view
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Hydrogel sheets seeded with cells were visualized using phase contrast microscopy 8, 24 and 
48 h after cell seeding. As shown in Figure 2.9B, after 8 h of incubation, most cells seeded on 
non-functionalized hydrogels remained spherical indicating minimal cell adhesion while cells 
seeded on functionalized hydrogels started to adhere and spread. After 48 h of incubation, 
cells seeded on non-functionalized hydrogels remained unattached while a notable increase 
in cell density was observed in functionalized hydrogels indicating cell proliferation. 
Therefore, SLA printed PEGDA hydrogels are cell compatible and can promote cell adhesion 
and proliferation with proper bio-functionalization. 
 
Figure 2.9 A) A schematic diagram illustrating CRL-2922 cells seeded on RGD peptides functionalized 
printed hydrogel sheets. The resin was composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 1.2 mg/mL 
QY. The exposure time for each layer was 60 s. B) Phase contrast microscopic graphs of cells seeded 
on both functionalized and non-functionalized hydrogels sheets after 8, 24 and 48 h of incubation. 
Scale bar represents 100 µm. 
 
2.6 Perfusion of printed PEGDA microchannels with full 3D design freedom 
First, we verified that printed fluidic channels can be perfused. Cylinder channel 
connectors (Figure 2.10A) were incorporated and printed in order to connect printed 
microchannels to external pumping. Blunt needles (Øout = 0.8 mm), fixed onto a 
micromanipulator device with two stages that allow for xyz multi-axis motion, was carefully 
aligned with printed channel connectors through a stereo microscope and subsequently 
inserted into the connectors (Figure 2.10A). The connector inner diameter (0.7 mm) was 
designed to be slightly smaller than the needle outer diameter to attempt a tight seal to the 
3D printed sheet
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needle. Perfusion tubing was then used to connect the needles and an external peristaltic 
pump. The whole perfusion setup is illustrated in Figure 2.10B. Successful perfusion of a 
single straight microchannel with a cross-section of 300 µm × 300 µm was routinely 
observed. 
 
 
Figure 2.10 A) A schematic diagram illustrating the perfusion setup based on a micromanipulator 
device. B) A photography of the perfusion setup composed of the following components: 1-2) the 
stages with metal joints; 3) the metal adapter connecting needles and perfusion tubing; 4) needles; 5) 
PMMA needle holder; 6) rotation stage that helps to align channel connector with needle; 7) hydrogel 
construct container. Scale bar represents 1 cm. 
 
Secondly, a series of channel systems with the same square channel cross-section of 300 
µm × 300 µm yet increasing 3D complexity, namely single 1D channel, double 2D channel, 
triple 3D channel and spiral 3D channel (Figure 2.11), were printed and perfused using the 
same perfusion setup. However, it was found that in case of spiral channels, channel 
occlusion was constantly observed despite well-defined features of the printed 300 µm × 
300 µm channels as previously showed. A larger channel cross-section (400 µm × 400 µm) 
was then implemented and afterwards the spiral channels were successfully perfused. These 
results show that perfusable channels with full 3D design freedom are easily accessible by 
our approach, which is difficult to achieve using other 3D printing techniques such as 
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extrusion-based printing. However, there was much room left for further resin optimization 
to achieve better vertical resolution. 
 
 
Figure 2.11 A-C) Channel system designs of increasing 3D complexity (400 µm × 450 µm channel 
cross-section for triple 3D channel and 400 µm × 400 µm for the rest of channels) before (B) and after 
(C) perfusion using red dyed liquid. The resin was composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 
1.2 mg/mL QY. The exposure time for each layer was 60 s.  
 
It should be noted that in case of triple 3D channel system, more than often only the two 
horizontal channels were perfused when all the three channels had the same square channel 
cross-section (400 µm × 400 µm) (Figure 2.12A). We suspected this was due to the higher 
fluidic resistance in the upwards and downwards sloped channel segments caused by 
reduced channel dimensions during printing. Fluidic resistance in microchannels can be 
calculated using the formula: 
  
𝑅𝑅 =  12𝜇𝜇𝜇𝜇
𝑤𝑤ℎ3𝐹𝐹
 (rectangular geometry) and 𝑅𝑅 =  8𝜇𝜇𝜇𝜇
𝜋𝜋𝑟𝑟4
 (circular geometry) 
 
where 𝑅𝑅 is fluidic resistance, 𝜇𝜇 is fluid viscosity, 𝐿𝐿 is the channel length, 𝑤𝑤 and ℎ are the 
width and height of the rectangular channel, respectively, 𝐹𝐹 represents a geometric form 
factor related to the rectangular shape and 𝑟𝑟 is the channel radius.12,172 Based on the 
formula, channel cross-section size has a major effect on fluidic resistance. The reduced 
channel dimensions caused by printing are due to the light penetration into the preceding 
layer, as discussed previously. The difference between the two horizontal channels and the 
vertical channel in case of the triple 3D channel system is that the vertical channel has a 
slope in vertical plane (Figure 2.12B). In case of the two horizontal channels, overcuring 
unreacted resin in the channel volume is mostly significant when the channel ceiling is 
printed (the last layer of a channel structure) while in case of the vertical channel it occurs in 
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every layer of the sloped part (Figure 2.12C). Therefore, more reduced channel dimensions 
in the vertical channel leads to higher fluidic resistance. The channel cross-section was then 
changed to 400 µm (V) × 450 µm (H) to reduce the fluidic resistance and subsequently all the 
channels were perfused (Figure 2.12B). 
 
 
Figure 2.12 A,B) The 3D design of the triple 3D channel system (A) and orthographic views (top and 
side) of the design (B). C) A schematic diagram illustrating how printing causes more reduced channel 
dimensions in sloped channel structure. The dashed line indicates the curing that leads to reduced 
channel dimension. 
 
The perfusion setup is generally adequate for testing if printed microchannels can be 
perfused. However, there are also some major limitations. Firstly, the equipment is 
cumbersome and thus makes it difficult to be utilized for perfusion cell culture studies which 
require a sterilized environment. Sterilization of the equipment with 70% ethanol and 
placing it in a laminar flow bench are not impossible but inconvenient. Secondly, once the 
alignment is done and the needles start to move downwards approaching the channel 
connectors, there is limited flexibility for movement in x-y plane and subsequently even 
slight misalignment could damage the structures when inserting the needles. Thirdly, due to 
the difficulty in perfectly aligning needles with channel connectors, leakage from the 
connectors is often observed shortly after the perfusion starts. Therefore, long-term, steady 
and leak-free perfusion cannot be easily achieved by this setup.  
 
2.7 Conclusion 
A commercial stereolithography printer was modified for hydrogel printing. An aqueous 
resin composed of PEGDA, LAP and QY was developed for SLA printing. Although 
microchannels with cross-section as small as 200 µm × 200 µm can be printed, perfusion of 
printed microchannels can only be achieved in channels with larger cross-section (at least 
300 µm × 300 µm). A perfusion setup based on a micromanipulator system was developed 
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and successful perfusion of a series of microchannels with increasing 3D complexity 
demonstrated that full 3D design freedom can be realized by our approach. We believe this 
demonstrated approach can serve as a useful guideline for researchers who want to work on 
stereolithographic 3D printing of hydrogels but do not have access to customized equipment 
and system. However, this proposed approach based on the commercial printer also poses 
some major limitations: 1) many experimental parameters are fixed by the manufacturer, 
such as fabrication platform step height and its initial approach distance, which offers 
limited flexibility; 2) the equipment for the perfusion setup is cumbersome and printed 
hydrogel constructs need to be carefully aligned with the needles, which is not easy. 
 
2.8 Experimental section 
2.8.1 Materials 
Poly(ethylene glycol) diacrylate (Mn 700 g mol-1, PEGDA) and Quinoline Yellow (QY) were 
acquired from Sigma-Aldrich and used as purchased. 
 
2.8.2 LAP synthesis 
LAP was synthesized based on a previously reported procedure.160 Briefly, at room 
temperature and in a nitrogen atmosphere, 3.2 g of 2,4,6-trimethylbenzoyl chloride (TCI 
America) was added dropwise to an equimolar amount of continuously stirred dimethyl 
phenylphosphonite (3.0 g, Sigma-Aldrich). The reaction mixture was stirred overnight, 
followed by the addition of a four-fold excess of lithium bromide (6.1 g, Sigma-Aldrich) 
dissolved in 100 mL acetone. The reaction mixture was then heated to 50 °C. After about 10 
min, a white solid precipitate formed. The mixture was cooled to room temperature and 
then filtered under vacuum. The filtrate was washed 3 times with acetone to remove 
unreacted lithium bromide, and the remaining solvent was removed in vacuum. 
 
2.8.3 Pre-treatment of cover slip surfaces 
The PEGDA hydrogels were printed onto pre-treated cover glasses for the purpose of 
easy handling, calling for prior chemical activation of the glass surface to secure the printed 
PEGDA to the glass support. The treatment was based on a previously reported 
procedure.173 The circular cover glasses (Ø 20 mm, VWR) were first cleaned via plasma 
treatment to remove organic contaminants. The cleaned glasses were then soaked in a 2% 
v/v 3-(trimethoxysilyl)propyl methacrylate (Sigma-Aldrich) solution in 95% v/v ethanol/water 
(pH adjusted to 5 by acetic acid) for 10 min, washed with pure ethanol for 3 times, and 
eventually baked at 105 °C for another 10 min. 
 
2.8.4 Projection stereolithography of PEGDA hydrogels 
Stereolithographic printing used a commercial printer (EnvisionTEC, Perfactory family, 
Type HX300T-JE) containing a DMD device (43 µm projected pixel pitch) and using a 405-nm 
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LED light source. The power density at the vat bottom was 0.9 mW cm-2 as measured using a 
UV power meter (OAI 306, Optical Associates). The home-built vat and fabrication platform 
were printed using a fused deposition printer (MakerBot: Replicator 2). Pre-treated cover 
slips were mounted to the fabrication platform using double-sided adhesive tapes. Non-
adhesive fluorinated ethylene propylene (FEP) foil (130 µm thick) was applied to the vat 
bottom to facilitate smooth release of each printed layer from the vat. 3D models were 
designed using Autodesk Inventor 2016 (Autodesk). The resulting design was sliced into a 
series of digital masks with a slicing thickness of 25 µm using the Perfactory software that 
comes with the printer. The aqueous resin consisted of 200 mg mL−1 PEGDA, 5 mg mL−1 LAP 
and 1.2 mg mL−1 QY. After adding resin to the vat, the fabrication stage was moved close to 
the vat bottom. After the formation of the first layer, the stage was raised by 25 µm for each 
additional digital mask exposure. Exposure time for each layer is 60 s. After printing, the 
object was immediately immersed in DI water for at least overnight to leach out remaining 
reagents and allowing it to reach its equilibrium swollen state prior to further use. 
 
2.8.5 Perfusion of printed PEGDA microchannels 
The two x-y-z stages were placed in front of each other with two fixed perpendicular 
metal joints on the sides, where the metal plate and needle holders were horizontally fixed. 
The metal adapters were fixed by metal clamps, connecting the stainless blunt needles (Øout 
0.8 mm, Sterican) with perfusion tubing and external pump. The needles were bent 90 
degree and subsequently were fixed onto the PMMA needle holders, keeping the needles 
stable and directly vertical. A rotation stage was placed between the two stages. The 
rotation stage made it easy to rotate the container where hydrogel constructs were placed 
so that channel connectors were aligned with the needles. A peristaltic pump (MasterFlex) 
was used. Printed constructs were fixated onto the container using double sided adhesive 
tapes, and the container filled with DI water. Aqueous solutions of red food dye (Dr. Oetker) 
were used as perfusion fluids. The tubing was pre-perfused with fluid to get rid of remaining 
air bubbles, and then the needles were inserted into the 3D printed channel connectors (Ø 
0.7 mm). Pumping proceeded at a flow rate of 200 µL min−1 and the channel perfusion was 
recorded by a phone camera. 
 
2.8.6 Cell culture 
CRL-2922 cells (ATCC) were cultured in Dulbecco’s modified Eagle’s medium with high 
glucose (DMEM, Biowest) supplemented with 10% v/v fetal bovine serum (FBS, Sigma-
Aldrich) and 1% v/v penicillin-streptomycin (P/S, Sigma-Aldrich). Cell cultures were passaged 
following the vendors’ manuals. 
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2.8.7 Cell compatibility of printed PEGDA hydrogel sheets 
Circular hydrogel sheets (Ø 11 mm, 0.4 mm thick) were printed and immersed in DI 
water for 24 h with two intermediate changes of water bath to allow the leaching of 
unreacted reagents. The hydrogel sheets were then placed in a 24-well plate and 300 µL 
aqueous solution of 0.2 mg mL−1 acrylated RGD peptides and 5 mg mL−1 LAP was added to 
each well, followed by 2 min of UV-A illumination (330-380 nm, peaking at 365 nm, 18 mW 
cm−2).174 The reaction mixture was removed and the structures were washed with DI water 3 
times. The hydrogel sheets were immersed in CRL-2922 culture medium containing 2% v/v 
P/S overnight to exchange the water in the hydrogel for culture medium. Before cell seeding, 
culture medium was removed and 500 µL of cell suspension (4 × 104 cells mL−1) was added to 
each well. Cells were then cultured at 37 °C in 5% CO2 for 48 h. Each sample was then 
visualized by phase contrast microscopy. Images of cells were taken at 8, 24 and 48 h after 
cell seeding. Acrylated RGD peptides were synthesized by conjugating acrylic acid N-
hydroxysuccinimide ester onto KG6RGDS peptides (CASLO). Acrylic acid N-
hydroxysuccinimide ester was first dissolved in dimethylformamide (DMF) at 4 mg mL−1 and 
RGD peptides in NaHCO3 buffer (50 mM, pH 8-8.5) at 1 mg mL−1. 500 µL of 4 mg mL−1 acrylic 
acid N-hydroxysuccinimide ester solution in DMF was added dropwise to 1 mL of 1 mg mL−1 
RGD peptide solution. The mixture was stirred for 2 h and transferred to a 100-500 Da 
molecular weight cutoff (MWCO) dialysis tubing (Spectra/Por), and dialyzed against DI water 
for 48 h. The final product was obtained through lyophilization. 
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Chapter 3:  
Hydrogel 3D microfluidics based on a home-built polychromic 
stereolithography printer 
The polychromic printer was built by Prof. Niels B. Larsen (Figure 3.1). It has projected 
13.68 µm pixel pitch, which is much better than the commercial printer (43 µm). The light 
exposure unit consists of a high power LED (light emitting diode) with multiple wavelengths, 
namely 365 nm and 450 nm, which has the potential for true multi-material SLA printing 
based on independent photopolymerization through different wavelengths. The printing 
process is controlled using custom written MATLAB code that synchronizes digital mask 
exposure on the DMD, light exposure, and fabrication stage movement via a linear stage. 
Such automated process based on programming code gives much flexibility in adjusting 
several experimental parameters according to resin performance, such as step height/slicing 
thickness. Detailed information regarding the home-built printer can be found in the 
experimental section. 
Based on the experience gained from printing PEGDA hydrogels using the commercial 
printer, the resin optimization for the home-built printer was conducted following similar 
procedures. However, due to the wavelength change regarding the light exposure unit, 
adjustments were made accordingly. 
 
 
Figure 3.1 A photography of our home-built polychrome stereolithography printer. 
 
3.1 Optimization of the spatial printing resolution for microchannels 
The same resin components were used and the concentrations of PEGDA and LAP were 
kept the same as before. However, based on the UV-Vis spectra of LAP and QY as shown in 
Figure 2.2, the absorbance of LAP at 365 nm is about 20 times the value of that at 405 nm 
while the absorbance of QY at 365 nm is only about one-fifth of the value at 405 nm. Several 
other dyes with higher absorption at 365 nm, such as methyl orange and 
DMD
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Fabrication platform
46 
 
diaminobenzophenone, were initially considered to replace QY. However, their poor water 
solubility prevents their practical use. Adjustments to the resin formulation was made 
according to Beer-Lambert law, 𝐴𝐴 = 𝜀𝜀𝜀𝜀𝜀𝜀, where A is absorbance, 𝜀𝜀 is molar extinction 
coefficient of a solute, 𝜀𝜀 is the length of light path and 𝜀𝜀 is the concentration of the solution. 
As an approximation, QY concentration was increased from 1.2 to 6 mg/mL, and exposure 
time was decreased from 60 to 3 s. The step height/slicing thickness was kept 25 µm as used 
before. This formulation was then used for preliminary test and hydrogel constructs with 
microchannels of various sizes were printed to evaluate the spatial printing resolution as 
before. The results showed that the home-built printer produced less well-defined 
microchannels using the aforementioned resin formulation (Figure 3.2). Even for the largest 
microchannel tested (square cross-section 400 µm × 400 µm), a notable reduction in vertical 
dimension was observed when using the home-built printer. 
 
 
Figure 3.2 A) A representative 3D design of a block with microchannels of desired dimensions. B) 
Optical micrographs of cross-sections of a series of printed square channels using both the home-built 
and commercial printer. The resin used for the commercial printer was composed of 200 mg/mL 
PEGDA, 5 mg/mL LAP and 1.2 mg/mL QY, and the exposure time for each layer was 60 s. The resin 
used for the home-built printer was composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 6 mg/mL QY, 
and the exposure time for each layer was 3 s. Scale bar represents 200 µm. 
Home-built printer Commercial printer
A
B
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The reduced vertical dimension was suspected to stem from overcuring and therefore 
the effect of both exposure time and QY concentration on the spatial printing resolution was 
investigated. First, microchannels printed with the same QY concentration yet different 
exposure times were characterized. It should be noted that since light exposure is controlled 
by custom programming code, multiple patterns in the same layer can be sequentially 
projected. As a result, various structures can be simultaneously printed using the same resin 
components yet different exposure times. Such flexibility allows for a more efficient 
optimization approach. In addition, due to the stronger absorption of LAP at 365 nm, 
photoinitiation is much faster, resulting in reduced fabrication time and subsequent 
enhanced optimization efficiency. As shown in Figure 3.3A, exposure times of 2.5 and 3.0 s 
resulted in more notable decrease in printed vertical dimensions, while exposure times 
between 1.7 and 2.0 s did not show significant difference in printed channel dimensions. 
Exposure times below 1.7 s were also explored, however, mechanically stable structures 
cannot be printed, as shown in Figure 3.3B. 
 
 
Figure 3.3 A) Measured printed channel dimensions versus design dimensions (error bars show the 
standard deviation, n = 3) from optical micrographs of cross-sections of a series of square channels 
printed using the same resin components yet different exposure times for each layer. The resin was 
composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 6 mg/mL QY. B) A photography (top view) of four 
hydrogel blocks with microchannels printed using the same resin components yet different exposure 
times. In case of exposure time of 1.6 s, layers started to detach from each other, indicating a weaker 
bonding between neighboring layers and thus mechanical unstable structures. 
 
Although decreasing exposure time helped to print better defined microchannels, overall 
QY concentration of 6 mg/mL is not sufficient for high spatial printing resolution. Therefore, 
QY concentration was increased to 9 mg/mL and microchannels were printed and 
characterized as before. Different exposure times were also explored, however, it was found 
that exposure times below 2.5 s could not produce mechanical stable structures when using 
9 mg/mL QY. Exposure times between 2.5 and 3.0 s did not show significant difference 
1.6 s 1.7 s 1.8 s 1.9 s
2 mm
500 µm
6 mg/mL QY
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(Figure 3.4A). Hence, exposure time of 3.0 s was selected in order to keep a balance 
between mechanical stability and fabrication speed. As shown in Figure 3.4B, increased QY 
concentration largely improved the spatial printing resolution. Moreover, microchannels of 
square cross-section as small as 100 µm × 100 µm were clearly visible using optical 
microscopy, while in case of 6 mg/mL QY they were completely occluded (Figure 3.4C). 
 
Figure 3.4 A) Measured printed channel dimensions versus design dimensions (error bars show the 
standard deviation, n = 3) from optical micrographs of cross-sections of a series of printed square 
channels. The resin was composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 9 mg/mL QY. B) Measured 
printed channel dimensions versus design dimensions (error bars show the standard deviation, n = 3) 
from optical micrographs of cross-sections of a series of printed square channels using different QY 
concentrations yet the same exposure time for each layer (3 s). C) Optical micrographs of cross-
sections of a series of printed square channels using different QY concentrations yet the same 
exposure time for each layer (3 s).  
 
Despite well-defined features of the printed 100 µm × 100 µm channels using 9 mg/mL 
absorber, as observed by optical microscopy, the resulting channels could not be perfused. A 
higher absorber concentration (12 mg/mL) was employed to minimize the risk of random 
channel occlusion as well as to further push the spatial printing resolution, but this resulted 
in mechanically unstable structures, similar to what was observed in Figure 3.3B. The step 
height/slicing thickness was then decreased from 25 µm to 20 µm to enhance the bonding 
between neighboring layers and consequently robust structures were successfully printed 
using 12 mg/mL absorber. With the adjusted resin formulation and printing procedure, 
microfluidic channels with cross-sections of 100 µm × 100 µm can be faithfully printed 
(Figure 3.5A,B) and are fully functional, as demonstrated by successful perfusion of a single 
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channel stepwise narrowing from a cross-section of 400 µm × 400 µm to 100 µm × 100 µm 
after printing (Figure 3.5C). 
 
Figure 3.5 A) Measured printed channel dimensions versus design dimensions (error bars show the 
standard deviation, n = 3) from optical micrographs of cross-sections of a series of printed square 
channels using the resin formulation consisting of 200 mg/mL PEGDA, 5 mg/mL LAP and 12 mg/mL QY. 
Exposure time of 3 s for each layer and a step height of 20 µm are adopted along with the resin 
formulation. B) Optical micrographs of cross-sections of a series of printed square channels using the 
optimized resin formulation. C) Stepwise narrowing channel with square cross-section from 400 µm × 
400 µm to 100 µm × 100 µm printed using optimized resin formulation and perfused with red dyed 
fluid. The insert shows the design of the narrowing channel. 
 
Later, we also evaluated printing of circular geometries of decreasing diameters and the 
resulting channel cross-sections are well defined, although the intrinsic grid geometry of the 
light exposure unit (a Digital Mirror Device) causes jagged perimeters of the smallest 
diameter designs (Figure 3.6). To our best knowledge, few reports have shown the printing 
of perfusable micro-channels approaching the dimensions of larger arterioles and venules175 
within hydrogel materials. 
 
 
Figure 3.6 A) Optical micrographs of cross-sectioned 3D printed channels of circular design with 
diameters of Ø 100, 200 and 300 µm. Resin consisted of 200 mg/mL PEGDA, 5 mg/mL LAP and 12 
mg/mL QY. Exposure time of 3 s for each layer and a step height of 20 µm are adopted along with the 
resin formulation. 
 
The effect of LAP concentration on printing was also investigated, and as shown in Figure 
3.7, LAP concentration less than 5 mg/mL resulted in mechanically unstable structures. In 
theory, mechanically stable structures could be printed with doubled exposure time (thus 
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doubled light dose) when using 2.5 mg/mL LAP, however, that would also double the 
fabrication time. Although the value of 5 mg/mL was used based on our group’s previous 
work on patterning PEGDA hydrogels through single light exposure rather than 3D printing, 
it turns out to be translated to 3D printing process well. 
 
 
Figure 3.7 The 3D design of a hydrogel block containing microchannels and optical micrographs of 3D 
printed hydrogel blocks with microchannels using different LAP concentrations. The rest of the resin 
consisted of 200 mg/mL PEGDA and 12 mg/mL QY. Exposure time of 3 s for each layer and a step 
height of 20 µm are adopted along with the resin formulation. When using 2.5 mg/mL, channel 
structures failed to be printed out while the whole block structure was not printed out when using a 
even lower LAP concentration (1 mg/mL). Scale bar represents 500 µm. 
 
Therefore, the resin composed of 200 mg/mL PEGDA, 5 mg/mL LAP and 12 mg/mL QY 
along with exposure time of 3 s for each layer and step height of 20 µm, was adopted for the 
remaining work as optimal printing configuration unless specified otherwise.  
Those results collectively suggest that experimental parameters regarding resin 
optimization are often not completely independent of each other. Increasing absorber 
concentration generally results in better spatial printing resolution, however, exposure time 
as well as step height needs to be adjusted accordingly in order to produce mechanically 
stable structures. Therefore, the combined effect of different experimental parameters is 
essential for the resin optimization process. Also, well defined features indicated by optical 
microscopy do not necessarily lead to functional microchannels in terms of perfusion due to 
random channel occlusion caused by curing of unreacted resin trapped in small cavities, 
therefore perfusion test should always be performed to confirm that printed microchannel 
can actually be perfused. 
 
3.2 Swelling and mechanical properties of 3D printed PEGDA hydrogels 
As mentioned in the previous chapter, an aqueous resin is essential because it minimizes 
dimensional changes caused by post-printing swelling in aqueous medium. In a hydrogel, it is 
the chemical potential that drives water in between chains and the elastic retractive forces 
of the network that push the water out.176 The equilibrium is called the equilibrium degree 
of swelling and is defined either as the mass equilibrium degree of swelling (𝑞𝑞) or the 
volumetric equilibrium degree of swelling (𝑄𝑄):176 
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𝑞𝑞 =  𝑀𝑀𝑠𝑠
𝑀𝑀𝑑𝑑
 ,𝑄𝑄 =  𝑉𝑉𝑠𝑠
𝑉𝑉𝑑𝑑
= 1 +  𝜌𝜌𝑝𝑝
𝜌𝜌𝑠𝑠
 (𝑞𝑞 − 1) 
 
with 𝑀𝑀𝑠𝑠 and 𝑀𝑀𝑑𝑑  being the mass of the swollen and the dry gel, 𝑉𝑉𝑠𝑠 and 𝑉𝑉𝑑𝑑 being the volume 
of the swollen and dry gel, and 𝜌𝜌𝑝𝑝 and 𝜌𝜌𝑠𝑠 being the density of the polymer and the solvent, 
respectively. 𝑞𝑞 is easy to measure by weighing both the swollen and dry samples. Since the 
dimensional change due to post-printing swelling is more of interest, the printed sample is 
also weighed immediately after printing and then transferred to a water bath where its 
weight is continuously measured until it remains constant. As shown in Figure 3.8, the 
printed hydrogels reach their equilibrium slightly swollen state within 4 h after being 
transferred to a water bath, and only a 10% increase in volume was observed when reaching 
swollen state, which indicates only a 2% increase in each dimension. Therefore, structures 
can just be printed as designed without extra consideration for compensating dimensional 
changes due to post-printing swelling. Additionally, all the dimensional measurements 
presented so far were performed after the printed structures were immersed in water for at 
least overnight. 
 
 
Figure 3.8 Time-dependent volumetric swelling ratio of 3D printed solid PEGDA objects (10 mm × 10 
mm × 3.5 mm) immediately after printing (0 h) and after selected times of immersion in DI water (O/N 
= overnight). Error bars show the standard deviation, n = 3. 
 
It should be noted that it is not trivial to obtain the dry weight of samples. Initially 
samples were dried at 140 oC to speed the process. However, it was found that the weight 
kept decreasing even after 2 days (Figure 3.9A). It was suspected that PEGDA underwent 
thermal/oxidative degradation at such high temperature.177–179 Therefore, several other 
approaches were adopted in order to make sure samples are completely dried but without 
degradation: 1) dry at a lower temperature, namely 60 oC; 2) dry at 50 oC in a vacuum 
chamber; 3) exchange water in samples with methanol and then dry at 50 oC in a vacuum 
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chamber. As shown in Figure 3.9B, all those three approaches gave similar results and the 
weight obtained was used as dry weight of samples. 
 
 
Figure 3.9 A) Time-dependent weight change of 3D printed solid PEGDA objects (10 mm × 10 mm × 
3.5 mm) when drying at 140 oC. Time of 0 h denotes the swollen weight in water. Error bars show the 
standard deviation, n = 3. B) Time-dependent weight change of 3D printed solid PEGDA objects (10 
mm × 10 mm × 3.5 mm) when drying at 60 oC, at 50 oC under vacuum or first swelling in methanol and 
then drying at 50 oC under vacuum. Time of 0 h denotes the swollen weight either in water or 
methanol. Printed hydrogels swell less in methanol than water. Error bars show the standard 
deviation, n = 3. 
 
Since mechanical properties are important for long-term use of printed constructs, the 
shear modulus of printed PEGDA hydrogels were characterized. Shear modulus is defined as 
the ratio of shear stress to the shear strain, and it is one of several quantities for measuring 
the stiffness of materials. As shown in Figure 3.10, our printed PEGDA hydrogels have a 
shear modulus of about 0.4 MPa, which enables printed constructs to withstand the needle 
insertion during perfusion. In comparison, a 15% gelatin hydrogel has a shear modulus of 
only about 5 kPa,180 suggesting that it might not be a good candidate material for hydrogel 
constructs used for long-term flow perfusion. 
 
Figure 3.10 Uniaxial compression of a 3D printed solid PEGDA cylinder (Ø6 mm; height 5 mm). The 
measured stress is displayed versus λ-λ-2, where λ is the extension ratio. Linear fitting using ordinate 
values from 0.2 to 0.8 (dashed line) yields a shear modulus of 0.43 MPa. 
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3.3 Perfusion of printed PEGDA microchannel networks 
In the previous chapter, a perfusion setup based on a micromanipulator device was 
introduced. However, the setup was cumbersome and even slight misalignment could cause 
irreversible damages to the hydrogel constructs. Therefore, a more facile perfusion setup 
was developed and adopted for the remaining work (Figure 3.11). 
 
 
Figure 3.11 A photography of a facile perfusion setup based on flexible micro-tubing. Needles are 
manually inserted to channel connectors.  
 
The needle insertion can easily be handled manually, which offers much flexibility during 
insertion and thus make it much easier to form tight seals. However, the use of a 
micromanipulator device in the first place was to fixate needles onto the stage so no/limited 
stress would be placed on hydrogel constructs when connecting the needles to the pump. 
When needles are manually inserted, hydrogel constructs must maintain the stability of 
needles as well as withstand any stress generated during and/or after connecting the 
needles to the pump through tubing. In order to minimize any potential stress placed on the 
hydrogel constructs, flexible micro-tubing was used between the needles and the tubing 
connected to the pump. Also, mechanical stability of our printed hydrogel constructs also 
contributes to the successful application of this modified perfusion setup. With such facile 
and flexible setup, simultaneous independent perfusion of the separate channels of a dual 
channel scaffold is steadily achieved, while leakage was often observed using the 
micromanipulator based perfusion setup (Figure 3.12). 
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Figure 3.12 A) Design of a dual-channel model in perspective and in cross-section with square 
channels of side length 300 µm. B) Printed PEGDA dual-channel construct perfused with separate 
dyed liquids simultaneously using flexible micro-tubing. C) Printed PEGDA dual-channel construct 
perfused with separate dyed liquids simultaneously using a micromanipulator device. Leakage of dyed 
liquids was observed at either inlet or outlet. 
 
Furthermore, stable leak-free perfusion for at least one week is routinely observed, 
documented by time-lapse video of steady-state diffusion concentration gradients of a 
perfused dye solution across the channel walls (Figure 3.13A,B). As an approximation of one 
dimensional diffusion situation, time-dependent diffusion distance of dye molecules was 
measure by analyzing snapshots of a recorded perfusion video at different time points, and 
the results (Figure 3.13C) fit the one-dimensional Einstein-Smoluchowski relation (𝑑𝑑2 = 2𝐷𝐷𝐷𝐷) 
well, indicating well-defined diffusion characteristics can be realized within our printed 
PEGDA hydrogels using such facile perfusion setup. 
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Figure 3.13 A) Snapshots of a 7 day-perfusion video at different time points during the first 7 h and 
their converted grey scale images. The intersection point of the horizontal and vertical dash line was 
defined as the starting point (zero distance) and the diffusion distance was measured along the 
vertical dash line starting from the intersection, as indicated by the white arrow in the grey scale 
image at 420 min. B) 3D design of the hydrogel construct used in this study, which contains a single 
straight circular channel (Ø 300 µm). C) The squares of measured one dimensional diffusion distance 
plotted against diffusion time.  
 
Later, as what was discussed in the previous chapter, we printed a series of channel 
systems with increasing 3D complexity, which were afterwards successfully perfused (Figure 
3.14). These results show that perfusable channels with full 3D design freedom are easily 
accessible by our approach, while being a significant challenge using current PDMS-based 
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microfluidic manufacturing processes or extrusion printing. Furthermore, with the home-
built printer, a 3D spiral microchannel of square cross-section as small as 200 µm × 200 µm 
can be faithfully printed as well as perfused, while the commercial printer could only print 
perfusable 3D spiral microchannel of square cross-section no smaller than 400 µm × 400 µm. 
 
 
Figure 3.14 Optical micrographs of 3D printed and perfused PEGDA channel networks (200 µm (V) × 
250 µm (H) rectangular channel cross-section for the channel in the vertical plane in triple 3D 
geometry and 200 µm × 200 µm square channel cross-section for the rest of channels) of increasing 
3D complexity from dual planar configuration, triple 3D geometry to spiral geometry. The inserts 
show the respective CAD designs. 
 
Also, it should be noted that similar to what was discussed in the previous chapter, the 
dimension of the channel in vertical plane in case of triple 3D geometry needs to be enlarged 
a bit to compensate for the higher fluidic resistance due to printing process. However, as 
shown in Figure 3.15, all the channels in the triple 3D geometry printed by our home-built 
printer can be simultaneously perfused with identical square cross-section of 300 µm × 300 
µm. When channel dimensions are further decreased to 200 µm × 200 µm, the channel in 
the vertical plane needs to be enlarged a bit in order to achieve perfusion of all the channels. 
Those results collectively suggest that the spatial resolution of the home-built printer is 
much better than the commercial one since such compensation is only necessary for 
microchannels with cross-sections smaller than 300 µm × 300 µm while in case of the 
commercial printer the compensation is required even for microchannels with cross-section 
of 400 µm × 400 µm. It stands to reason that the degree of overcuring, which depends on 
resin formulation and light exposure, should be similar regardless of the design dimensions 
of microchannels and therefore its effect is more significant in case of microchannels with 
small dimensions. Therefore, proper adjustments need to be made when necessary in order 
to compensate for the deviation of the printed channel dimensions from the design 
dimensions due to the resolution limit. 
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Design Perfusion images 
 
 
 
Dimension unit: mm 
 
 
Scale bar represents 500 µm. 
 
 
Dimension unit: mm 
 
Scale bar represents 400 µm. 
 
 
Dimension unit: mm 
 
 
Scale bar represents 400 µm. 
 
Figure 3.15. 3D design of a triple geometry channel system and the orthographic views (top and side) 
of a 3D design of a triple geometry microchannel system and the photographs of actually printed 
hydrogel construct with microchannels perfused with red dye liquid. When microchannels have a 
cross-section smaller than 300 µm × 300 µm, the channel in the vertical plane needs to be enlarged in 
order to compensate for the higher fluidic resistance stemming from the reduced channel dimensions 
Top view
Side view
Top view
Top view
Top view
Perspective view
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during printing process and subsequently to ensure simultaneous perfusion of all the channels. 
Therefore proper adjustments need to be made due to the resolution limit. 
 
3.4 Cell compatibility of the printed micro-perfusable chip constructs 
Similar to what was discussed in the previous chapter, we first investigated the cell 
compatibility of SLA printed bowl-shaped constructs (Figure 3.16). Bowl structures were 
used because their overall planar bottom surface greatly facilitated the visualization of cells 
by microscopy compared to sealed microchannels. Human umbilical vein endothelial cells 
(HUVEC) instead of endothelial cell line CRL-2922 were used for better biological relevance. 
As discussed before, the surfaces of printed constructs need to be functionalized with cell 
adhesive ligands prior to cell seeding. However, gelatin methacrylate (GelMA) is used 
instead of RGD peptides because GelMA can be used in a large quantity at a much lower cost 
than RGD peptides. GelMA is widely used as a photocrosslinkable hydrogel matrix for 
accommodating live cells.181 In order to avoid the formation of bulk GelMA hydrogels during 
functionalization, a low GelMA concentration (10 mg mL−1) is adopted.182 PEGDA structures 
with pendant unreacted acrylate groups were exposed to LAP-containing GelMA solution 
and subsequently to UV-A illumination. Seeded HUVECs adhered and assembled into a 
nearly confluent layer with negligible observable cell death after culture for 24 h (Figure 
3.16), demonstrating the cell compatibility of the printed and modified constructs. 
 
 
Figure 3.16 A schematic diagram of bio-functionalization of printed bowl structures using cell 
adhesive protein, gelatin methacrylate (GelMA), and composite fluorescence images of human 
umbilical vein endothelial cells (HUVECs) 24 h after being seeded on functionalized PEGDA bowl 
structures: live cells (calcein-AM, green), dead cells (propidium iodide, red) and nuclei (Hoechst 33342, 
blue). The seeding densities were 7 × 104,  1.4 × 105 and 2.1 × 105cells cm-2 (from left to right). 
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Next, we printed and exposed a circular channel (Ø 300 µm) with its inner wall 
functionalized with GelMA to a HUVEC cell suspension by perfusion. The use of a low GelMA 
concentration (10 mg mL−1) resulted in specific channel wall functionalization without 
unwanted bulk GelMA hydrogel formation in the fluidic channels. After incubation for 24 h 
HUVEC cells lined the vessel-like wall (Figure 3.17). This demonstrates the applicability of our 
light-based synthetic hydrogel printing and biofunctionalization approach to produce in vitro 
endothelialized fluidic channel systems with physiological complexity. 
 
Figure 3.17 A) A schematic diagram of bio-functionalization of printed microchannel walls using cell 
adhesive protein, gelatin methacrylate (GelMA), and a design of a dual-channel model with cylindrical 
Ø 300 µm channels, with the insert showing the channel cross-section in red. B) Confocal laser 
scanning micrographs of live HUVEC cells lining the printed and functionalized PEGDA micro-channel 
walls. 
 
It should be noted that microchannels seeded with endothelial cells were initially 
sectioned using a blade prior to visualization because the pixelated nature of printed 
structures stemming from digital mirror device strongly scatters the light and subsequently 
prevents 3D imaging through an intact microchannel structure, as shown in Figure 3.18A. 
However, due to the microscale size of printed microchannels, sectioning samples proved to 
be very challenging. Therefore, the printing configuration was adjusted by Prof. Niels B. 
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Larsen and samples that minimize the light scattering were printed and used for visualization, 
as shown in Figure 3.18B. 
 
 
Figure 3.18 A,B) Fluorescence microscopic images of seeded endothelial cells in non-sectioned 
microchannels in case of strong (A) and less light scattering (B), respectively. Cells were stained with 
calcein-AM (green) and printed PEGDA hydrogel constructs also give green autofluorescence. 
 
3.5 Embedding of cell-laden matrices in printed perfusable hydrogel chips 
As a next step, we fabricated a true 3D chip unit with separate cell culture chamber and 
vascular-like fluidic networks, as illustrated in Figure 3.19, to address the current fabrication 
limitations for creating advanced in vitro models. The central culture chamber is surrounded 
by a multi-furcated perfusion network composed of 8 circular channels (~ Ø 200 µm) and 
traversed by a center channel (Ø 180 µm, Figure 3.19A,B) only supported by a narrow bridge 
with diamond shaped fenestrations (Figure 3.19A, insert). This design enables tissue cells to 
reside on all sides of the center channel. All the channels that are not in horizontal plane are 
designed to be slightly larger based on what was discussed in the previous section. The 
center channel is designed to be even smaller to compensate for the reduced fluidic 
resistance due to its overall shorter length. All those adjustments are based on the fluidic 
resistance formula as listed in the previous chapter and to ensure a more or less equivalent 
fluidic resistance among all the channels so they can be simultaneously perfused. First, the 
independent perfusion of the channel network and the culture chamber using aqueous dye 
solutions demonstrates the ability to introduce different materials into distinct chip 
construct volumes (Figure 3.19C). The observed slight blur along the chamber and channel 
perimeters is caused by fast diffusion of the small dye molecules into the surrounding 
diffusion-open PEGDA hydrogel in the time between loading the channels and recording the 
micrograph. Then, we separately perfused the channel network with LAP-containing 
acrylated rhodamine solution and the chamber with GelMA solution containing LAP and live-
stained 3T3 fibroblasts. Subsequent UV-A illumination of the printed device induced 
covalent binding of the rhodamine molecules diffused into the walls of the channel network 
200 µm 200 µm
Sample with strong light scattering Sample with less light scatteringA B
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and cross-linking of the cell-laden hydrogel in the culture chamber. Confocal imaging 
confirmed the coexistence of perfused fluidic channels and encapsulated live cells (Figure 
3.19D-F). 
 
 
Figure 3.19 A,B) Design of a culture chamber with 8 surrounding and one central traversing vascular 
channels (A) and its corresponding cross-sectional view in the YZ plane (B) showing all the design 
channel dimensions. The insert in (A) shows the cross-sectional view in the XZ plane. C) Photograph 
(top view) of the printed PEGDA construct with the vascular network perfused by red dyed liquid and 
the chamber perfused by blue dyed liquid.  D) Fluorescence micrograph (top view) of the construct 
with the vascular network walls coated by rhodamine (red) and the chamber filled with GelMA 
hydrogel laden with live fibroblasts (calcein AM, green). E) Confocal fluorescence micrograph 
(rhodamine, red) of a cross-sectioned slice of the construct showing perfusion of microfluidic 
channels. f) Confocal fluorescence micrograph of a cross-sectioned slice of the construct showing the 
perfused vascular network (rhodamine, red), live 3T3 fibroblasts (green) and the PEGDA construct 
outline (transmitted light, gray). 
 
Those results demonstrate the flexibility of our approach for embedding a highly 
compliant cell-laden matrix in a mechanically stable yet diffusion-open hydrogel microfluidic 
chip of intermediate compliance. However, two common problems were often observed 
during the embedding procedure. Firstly, although channel dimensions were adjusted to 
compensate for the fluidic resistance difference, all the channels cannot always be 
simultaneously perfused (Figure 3.20A). Secondly, the culture chamber was often not fully 
filled with cell-laden matrices (Figure 3.20B). Although all the tubing was always pre-filled 
with perfusion medium before needle insertion, air bubbles could still occur during 
perfusion partly due to the fact that GelMA can function as a surfactant, thus effectively 
creating void space in the culture chamber. Moreover, the structural supports of the center 
channel in the chamber could obstruct the flow and complicate the fluidic dynamics, thus 
preventing effective filling of the culture chamber. 
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Figure 3.20 A,B) Fluorescence micrographs of cross-sectioned slices of the constructs showing the 
perfused vascular network (rhodamine, red), live 3T3 fibroblasts (green) and the PEGDA construct 
outline (transmitted light, gray). In (A) one channel was perfused while in (B) much void space was 
observed in the culture chamber. The green color of the background was due to the autofluorescence 
of printed PEGDA hydrogels. 
 
In order to address those two common problems, a new perfusion chip design is 
implemented (Figure 3.21). The main concept is similar, but with a few adjustments. Firstly, 
a loading chamber is incorporated right above the culture chamber so that embedding of 
cell-laden matrices can be accomplished by simple pipetting, and the perfusion channel 
connected to the chamber is intended to remove all remaining liquid medium by suction 
before loading rather than to fill the chamber (Figure 3.21A,B). It should be noted that cells 
seeded in the loading chamber will consume the oxygen diffused from the top and therefore 
cells in the culture chamber can only survive on the oxygen diffused from the channel 
network. Secondly, the sloped parts of all branched channels are enlarged so the effect of 
overcuring on printed channel dimensions can be minimized as previously discussed, which 
results in more or less equivalent fluidic resistance within perfusion network, and therefore 
the same design dimension is adopted for all the channels (Figure 3.21C,D). 
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Figure 3.21 A,B) Design of a culture chamber with 6 surrounding and one central traversing vascular 
channels (A) and its corresponding cross-sectional view (B). C,D) Design of an adjusted multi-furcated 
channel network with enlarged sloped part (C) and its corresponding cross-sectional view (D) showing 
all the design channel dimensions.  
 
To test if the culture chamber can be fully filled using the adjusted design, pre-gel GelMA 
solutions containing LAP and fluorescence microbeads were carefully pipetted into the 
loading chamber that was previously fully emptied and subsequently exposed to UV-A 
illumination. Confocal imaging of a sectioned sample confirmed that the chamber was fully 
filled with gelled GelMA after illumination (Figure 3.22A). Perfusion check was also 
performed to test the adjusted design of channel network and it was shown that 
simultaneous perfusion of all channels can be achieved rather easily (Figure 3.22B). 
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Figure 3.22 A) Confocal fluorescence micrograph of a cross-sectioned slice of the construct showing 
the culture chamber filled with fluorescence microbeads (green) encapsulated in GelMA and the 
PEGDA construct outline (transmitted light, gray). B) Micrograph of a cross-sectioned slice of the 
construct showing the channel network perfused with red dyed liquid. 
 
The long-term steady perfusion has been demonstrated in a single straight circular 
microchannel, as showed in Figure 3.13. The same test was then performed in a culture chip 
construct with both a multi-furcated channel network and a culture chamber to see if a 
structure with more intricate structural features can withstand long-term and continuous 
convective flow. The results showed that the construct can be steadily perfused for at least a 
week, snapshots of the recorded perfusion video at different time points are shown in 
Figure 3.23. The dye diffuses from the channel volume through the diffusion open PEGDA 
matrix and establishes a stable color (concentration) gradient near the object’s perimeters 
within the first 12 h. The gradient remains stable over the 7 days captured in the video, via 
daily exchange of the surrounding water bath that would otherwise become saturated with 
the diffusing dyes. 
 
 
Figure 3.23 Long-term perfusion of a 3D printed PEGDA culture chip containing a multi-furcated 
channel network (each channel of cross-section Ø 200 µm) as well as a culture chamber immersed in 
a water-filled petri dish with change between dyed liquids (blue, red and undyed DI water) every day. 
 
After the demonstration of effective chamber filling as well as steady perfusion of 
channel network, we further developed a perfusion culture platform to see if the 
incorporated microfluidic network can sustain a healthy true 3D culture in the long term. 
First, we optimized LAP concentration for cell encapsulation in order to ensure adequate cell 
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viability after gelation of GelMA via radical photopolymerization. Before, cells were 
encapsulated and then immediately visualized to demonstrate the filling of the culture 
chamber. However, radicals formed during gelation can be toxic to cells,160 and therefore it 
is important to use a suitable LAP concentration so GelMA can be properly gelled with 
minimized cytotoxic effect on long-term culture. Cell-laden pre-gel GelMA solution 
supplemented with different LAP concentrations were added to a standard well plate and 
subsequently exposed to UV-A irradiation. After a 7-day culture period with intermediate 
medium change every 2 days, cells were visualized using live/dead staining. As shown in 
Figure 3.24A and B, a high concentration of LAP (5 mg/mL) had significant deleterious effect 
on cell viability and almost no cells were alive after 7-day culture, while adequate cell 
viability was observed using a low LAP concentration (0.5 mg/mL), but only limited to a thin 
layer (100-200 µm thick) right below the surface. Those results confirmed that a suitable LAP 
concentration is essential during gelation process and that cells embedded deep within 
hydrogels without proper vascularization cannot survive in the long term due to the 
diffusion limit of oxygen and other necessary nutrients. Considering the fact that cell-laden 
GelMA embedded in our printed hydrogel culture chips needs to be sectioned for 
visualization, a higher concentration of both GelMA and LAP is preferred so formed GelMA 
hydrogels can withstand the sectioning process better. Thus the same test was performed 
using a higher concentration of both GelMA (100 mg/mL) and LAP (1 mg/mL), but samples 
were cultured only for 2 days to mainly investigate the effect of encapsulation process on 
cell viability. As shown in Figure 3.24C, sufficient cell viability was observed after 
encapsulation probably due to the fact that radicals are consumed faster by GelMA at a 
higher GelMA concentration. Therefore, such formulation is adopted for cell encapsulation 
for the remaining work. 
 
 
Figure 3.24 A,B) Confocal images of HT-29 cells 7 day after being encapsulated in 50 mg/mL GelMA 
with either 0.5 mg/mL (A) or 5 mg/mL (B) LAP: live cells (calcein-AM, green) and dead cells (propidium 
iodide, red). The seeding density was 5 × 106 cells/mL. C) Confocal images of HT-29 cells 2 day after 
being encapsulated in 100 mg/mL GelMA with 1 mg/mL LAP: live cells (calcein-AM, green) and dead 
cells (propidium iodide, red). The seeding density was 10 × 106 cells/mL. 
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The previously discussed perfusion setup in this chapter was applied with minor 
adjustments to meet the requirement of a sterilized environment for cell culture studies. 
Since a sterilized environment prefers a closed system, the container for printed hydrogel 
chip, which is usually a petri dish, needs to be properly capped during perfusion culture to 
minimize the risk of contamination and therefore CO2 laser is utilized to create holes on petri 
dish lids for needle insertion (Figure 3.25). The holes are designed to be larger than 
necessary to allow for flexibility in case of misalignment. In addition, the holes are sealed by 
Parafilm prior to the insertion process to avoid contamination. 
 
 
Figure 3.25 Two needles mounted to the micro-tubing were connected to a printed hydrogel chip in a 
water-filled petri dish with two holes on its lid. The insert shows the same setup without Parafilm 
covering the holes.  
 
The whole perfusion culture setup is illustrated in Figure 3.26. It consists of a medium 
reservoir, a multi-channel peristaltic pump, a sample incubator, a heated circulating water 
bath and a gas supply unit. An external supply of 95% air and 5% CO2 is used to maintain 
constant pH of culture medium in both the medium bottle and petri dishes containing the 
printed hydrogel chips. The medium reservoir is composed of two glass bottles with holes 
drilled in their lids for tubing, one for culture medium and the other filled with sterilized 
water for humidifying the gas mixture before entering the medium bottle in order to 
minimize evaporation of medium. A 0.22 µm filter is connected to the end of the gas tubing 
to avoid contamination. A water bath is used to keep both the medium and humidifying 
bottle warm. Samples are kept inside a microscope stage incubator without a lid to avoid 
constraints on the tubing. Instead, a plastic bag is wrapped around the incubator to 
minimize heat and gas exchange with surrounding atmosphere. Heated circulating water 
bath is used to keep the incubator warm. The gas mixture also passes through the heated 
circulating bath before entering the incubator. The multi-channel peristaltic pump allows for 
Hydrogel 
chip
Needles mounted 
to micro-tubing
Holes accommodating 
needles
Parafilm
5 mm
67 
 
simultaneous perfusion of multiple samples. Before perfusion culture starts, all the tubing is 
perfused by a large amount of 70% ethanol, followed by sterilized water using the peristaltic 
pump. The surfaces of all equipment are wiped with 70% ethanol prior to experiment. 
Printed samples along with all the glass bottles are sterilized by UV-C irradiation. Sterilized 
Samples are then transferred to a laminar flow bench for cell loading and subsequently 
connected to the pump through needle insertion and tubing. Although it is not a perfectly 
sterilized environment, culture medium used for perfusion is still completely transparent 
after a 7-day culture period, which indicates no or limited contamination (Figure 3.26C). 
 
Figure 3.26 A) A photograph of the perfusion culture setup. The system consists of a medium 
reservoir, a multi-channel peristaltic pump, a sample incubator, a circulating water bath and an 
external gas supply unit. The medium reservoir is continuously fed with a gas mixture (95% air and 5% 
CO2) humidified gas mixture to maintain pH and to minimize evaporation. The medium is circulated 
through an automated peristaltic pump. Samples are kept inside a stage incubator wrapped with a 
plastic bag with continuously fed warm circulating water and humidified gas mixture. B) Four samples 
were placed in the stage incubator and simultaneously perfused. C) A photograph of the culture 
medium used for perfusion after a 3-day culture period. 
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To test if perfusion culture can maintain a healthy 3D cell culture, colorectal 
adenocarcinoma cell line (HT-29) was encapsulated in GelMA solution and subsequently 
loaded into the printed hydrogel culture chip. After a 3-day and 7-day perfusion culture 
period, samples were sectioned and afterwards visualized using standard live/dead staining. 
Samples that were loaded with the same cell-laden GelMA and cultured without medium 
perfusion through channel network were used as controls (static cultures). Confocal imaging 
showed a higher fraction of live cells in the perfused samples (Figure 3.27), indicating that 
soluble factors such as oxygen and nutrients can continuously diffuse from channel network 
to culture chamber and consequently maintain a healthier cell culture. This demonstrates 
the potential of this facile approach for manufacturing robust hydrogel culture chips as in 
vitro cell culture models that can find many uses such as drug screening and in vitro disease 
modeling. 
 
Figure 3.27 Confocal fluorescence micrographs of cross-sectioned slices of the culture chamber in 
printed hydrogel chips showing the live HT-29 cells (calcein-AM, green), the dead cells (propidium 
iodide, red), and the PEGDA construct outline (transmitted light, gray) after either a 3-day or 7-day 
culture period in both static and perfusion culture conditions. Scale bar represents 200 µm. 
 
3.6 Printing and perfusion of a massively perfusable tissue chip 
Unpublished data: The authors would like to keep this section confidential until they are 
published. 
 
Static culture Perfusion culture
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3.7 Conclusion 
In summary, we have developed a new approach based on high-resolution 
stereolithography employing easily synthesized and commercially available starting 
compounds to produce in vitro vascular network-like hydrogel constructs with high 3D 
complexity, facile perfusion setup, and the possibility to culture cells in both the vascular 
networks and the defined interstitial volumes. In addition, this technique is suitable for 
production up-scaling without compromising spatial resolution and fabrication speed with 
the continuous advances in optical components developed for SLA. Further work should be 
performed to validate the proposed approach with respect to its use as fully functional in 
vitro models. Future studies will focus on detailed investigation of long-term cell culture 
behavior in 3D when the chemical microenvironment is modulated by compound perfusion 
through the vascular network-like constructs. This versatile platform opens new avenues for 
a number of biomedical applications, such as chemotaxis studies, drug development and in 
vitro disease modeling. 
 
3.8 Experimental section 
3.8.1 Materials 
Poly(ethylene glycol) diacrylate (Mn 700 g mol-1, PEGDA) and Quinoline Yellow (QY) were 
acquired from Sigma-Aldrich and used as purchased. 
 
3.8.2 LAP synthesis 
LAP was synthesized based on a previously reported procedure.160 Briefly, at room 
temperature and in a nitrogen atmosphere, 3.2 g of 2,4,6-trimethylbenzoyl chloride (TCI 
America) was added dropwise to an equimolar amount of continuously stirred dimethyl 
phenylphosphonite (3.0 g, Sigma-Aldrich). The reaction mixture was stirred overnight, 
followed by the addition of a four-fold excess of lithium bromide (6.1 g, Sigma-Aldrich) 
dissolved in 100 mL acetone. The reaction mixture was then heated to 50 °C. After about 10 
min, a white solid precipitate formed. The mixture was cooled to room temperature and 
then filtered under vacuum. The filtrate was washed 3 times with acetone to remove 
unreacted lithium bromide, and the remaining solvent was removed by vacuum. 
 
 
3.8.3 GelMA synthesis 
GelMA was synthesized based on a previously reported procedure.183 Briefly, a 100 mg 
mL−1 gelatin solution was first prepared by dissolving gelatin powder (Type A, 300 g bloom 
from porcine skin, Sigma-Aldrich) in Dulbecco’s phosphate-buffered saline (DPBS) at 60 °C 
for 2 h with vigorous stirring. Then the solution temperature was lowered to 50 °C and 0.14 
mL of methacrylic anhydride was added dropwise to the gelatin solution for each gram of 
gelatin in the solution (about 50% degree of methacrylation). The mixture was allowed to 
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react for 4 h at 50 °C with vigorous stirring. The methacrylation reaction was then quenched 
by diluting the mixture with DPBS pre-warmed to 40 °C to a GelMA concentration of 45 mg 
mL−1. GelMA was precipitated overnight by the addition of 100 mL ice-cold acetone to the 
diluted mixture. Acetone was then decanted from the precipitated GelMA, which was then 
dissolved in DPBS at 100 mg mL−1 at 40 °C. The warm GelMA solution was filtered under 
vacuum through a 0.2 µm filter (PES membrane, VWR vacuum filtration), transferred to a 12-
14 kDa molecular weight cutoff (MWCO) dialysis tubing (Spectra/Por 4), and dialyzed against 
deionized (DI) water at 40 °C for 3 days with frequent change of the dialysis media (twice a 
day) to remove remaining methacrylic acid. Finally, the GelMA was lyophilized for 2 days and 
subsequently stored at −20 °C prior to further use. 
 
3.8.4 Pre-treatment of cover slip surfaces 
The PEGDA hydrogels were printed onto pre-treated cover glasses for the purpose of 
easy handling, calling for prior chemical activation of the glass surface to secure the printed 
PEGDA to the glass support. The treatment was based on a previously reported 
procedure.173 The circular cover glasses (Ø 20 mm, VWR) were first cleaned via plasma 
treatment to remove organic contaminants. The cleaned glasses were then soaked in a 2% 
v/v 3-(trimethoxysilyl)propyl methacrylate (Sigma-Aldrich) solution in 95% v/v ethanol/water 
(pH adjusted to 5 by acetic acid) for 10 min, washed with pure ethanol for 3 times, and 
eventually baked at 105 °C for another 10 min. 
 
3.8.5 Projection stereolithography of PEGDA hydrogels 
Stereolithographic printing used a home-built high resolution printer based on 1-to-1 
projection of light reflected off a Digital Mirror Device (13.68 µm pixel pitch, DLP7000 UV, 
Texas Instruments, DMD) coupled to a V-7000 Hi-Speed controller (Vialux). The printing 
process proceeded using custom written MATLAB (MathWorks) code that synchronizes 
digital mask exposure on the DMD, light exposure using a 365-nm high power LED (LZ1-
00UV00, Ledengin), and fabrication stage movement via a linear stage (LNR50S, Thor Labs). 
The power density at the vat bottom was 10.9 mW cm-2 as measured using a UV power 
meter (OAI 306, Optical Associates). Pre-treated cover glasses were mounted to the 
fabrication stage. Non-adhesive fluorinated ethylene propylene (FEP) foil (130 µm thick) was 
applied to the vat bottom to facilitate smooth release of each printed layer from the vat. 3D 
models were designed using Autodesk Inventor 2016 (Autodesk). The resulting design was 
sliced into a series of digital masks with a slicing thickness of 20 µm using the open-source 
slicer software Slic3r. The aqueous resin consisted of 200 mg mL−1 PEGDA, 5 mg mL−1 LAP 
and 12 mg mL−1 QY. After adding resin to the vat, the fabrication stage was moved close to 
the vat bottom. The first digital mask was projected for an extended time of 15 s to ensure 
proper attachment of the polymer to the cover glass. After the formation of the first layer, 
the stage was raised by 20 µm for each additional digital mask exposure. The first 10 layers 
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(corresponding to ~200 µm thickness) were each exposed for 15 s followed by a gradual 
reduction of the exposure time to 3 s over the next 10 layers to minimize mechanical strain. 
All layers in the remaining part of the printed object, including all parts defining channel and 
chamber structures, were exposed for 3 s each (5 s for massively perfusable tissue construct). 
After printing, the object was immediately immersed in DI water for at least overnight to 
leach out remaining reagents and allowing it to reach its equilibrium swollen state prior to 
further use. Prior to dimensional measurements, printed samples were removed from cover 
slip using a blade. An array of micropillars as structural supports can be included at the 
bottom to facilitate smooth removal of samples from cover slip without damaging channel 
structures. 
 
3.8.6 Analysis of swelling properties of printed PEGDA hydrogels 
Solid PEGDA objects of size 10 mm × 10 mm × 3.5 mm were printed on a cover glass by 
stereolithography employing the optimized pre-polymer solution composition and printing 
conditions. Immediately after printing, surplus water was removed by quickly touching the 
cuboid’s surfaces with tissue, and its weight was determined. The sample was immediately 
re-immersed in DI water, and the procedure was repeated after 1, 2, 3, 4 h as well as after 
overnight immersion. The swollen cuboid was placed in an oven at 60 °C and the weight 
after overnight drying was used for calculating the volumetric swelling ratio. 
 
3.8.7 Analysis of mechanical properties of printed PEGDA hydrogels 
Solid PEGDA cylinders of Ø 6 mm and height 5 mm were printed on a cover glass by 
stereolithography employing the same pre-polymer solution composition and printing 
conditions used for printing perfusion constructs. The printed cylinders were released from 
the cover glass support by a scalpel and allowed to reach their equilibrium degree of 
swelling by immersion overnight in DI water. The mechanical properties of the still wet 
samples were analyzed on an Instron 5967 at a compression rate of 0.5 mm min-1 to a final 
extension ratio λ of 0.7. The data was analyzed using neo-Hookean rubber elastic theory for 
highly swollen hydrogels that predicts a linear dependence of the stress on λ-λ-2.184 A linear 
fit to the data in the λ-λ-2 range from 0.2 to 0.8 yields a hydrogel shear modulus of 0.43 MPa. 
 
 
3.8.8 Perfusion of printed PEGDA microchannel networks 
Blunt stainless needles (Ø 0.8 mm × 22 mm, Sterican) were mounted to 
polytetrafluoroethylene (PTFE) tubing (Øinner 0.30 mm and Øouter 0.50 mm, Adtech Polymer 
Engineering) that was connected to a peristaltic pump (MasterFlex) via Luer Lock connectors. 
Printed constructs were fixated onto the bottom of a polystyrene petri dish using double 
sided adhesive tapes, and the petri dish filled with DI water. Aqueous solutions of either red 
or blue food dye (Dr. Oetker) were used as perfusion fluids. The tubing was pre-perfused 
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with fluid to avoid bubbles, and the needles were inserted into the 3D printed inlet and 
outlet (Ø 0.7 mm). Pumping proceeded at a flow rate of 100 µL min−1 and the channel 
perfusion was recorded by either a phone camera (for short-term perfusion) or a stationary 
live camera (for long-term perfusion). In case of phone camera, the recorded videos were 
stabilized using the plugin TurboReg in the Fiji software package.185,186 In case of stationary 
live camera, a Python code was used to control the camera so that one image was taken 
every one minute. After recording, images were stacked to a time-lapse video using Fiji 
software. To measure diffusion distance of the dye molecules, images taken at different time 
points were converted to grey scale images using Fiji software. 
 
3.8.9 Cell culture 
Primary human umbilical vein endothelial cells (HUVECs) (Gibco) were cultured in 
Medium 200 (Gibco) supplemented with 2% v/v Large Vessel Endothelial Supplement 
(Gibco). Human colorectal adenocarcinoma cells (HT-29) (ATCC, HTB-38, Rockville, MD, USA), 
and 3T3 Swiss Albino cells (ECACC 85022108) were cultured in Dulbecco’s modified Eagle’s 
medium with high glucose (DMEM, Biowest) supplemented with 10% v/v fetal bovine serum 
(FBS, Sigma-Aldrich) and 1% v/v penicillin-streptomycin (P/S, Sigma-Aldrich). Cells were 
incubated at 37 oC in a humidified atmosphere with 5% CO2. All the cell cultures were 
passaged following the respective vendors’ manuals. HUVECs were not used beyond passage 
5. 
 
3.8.10 Cytotoxicity assay 
Bowl structures (Øinner 8 mm, Øouter 10 mm, 0.4 mm thick bottom, 2.5 mm overall height) 
were printed and immersed in DI water for 24 h with two intermediate changes of water 
bath to allow the leaching of unreacted reagents. 100 µL aqueous solution of 10 mg mL−1 
GelMA and 5 mg mL−1 LAP was added to each bowl, followed by 2 min of UV-A illumination 
(330-380 nm, peaking at 365 nm, 18 mW cm−2).174 The reaction mixture was removed and 
the structures were washed with DI water 3 times before being immobilized in a 6-well plate 
using double sided adhesive tape. HUVEC culture medium was added to the well plate to 
submerge each structure and the whole plate containing the structures was sterilized by 20 
min exposure of UV-C irradiation (254 nm, UV sterilization cabinet, Cleaver Scientific) in a 
laminar flow bench. The structures were immersed in HUVEC culture medium overnight to 
exchange the water in the hydrogel for culture medium. Before cell seeding, culture medium 
was partially removed so that each bowl structure was not submerged yet still moist. Then 
the culture medium inside each bowl was replaced with 100 µL HUVEC suspension. Cells 
were seeded at three densities, 7 × 104 cells cm−2, 1.4 × 105 cells cm−2, and 2.1 × 105 cells cm−2, 
respectively, and cultured at 37 °C in 5% CO2 for 24 h. Non-adherent cells were washed away 
using culture medium, and adhered cells were stained with calcein-AM (2 µg mL−1, 
Invitrogen), propidium iodide (PI, 2 µg mL−1, Sigma-Aldrich) and Hoechst 33342 (2 µg mL−1, 
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Sigma-Aldrich) for 1 h. Each sample was then characterized by fluorescence microscopy 
(AxioVert 100 M, Zeiss). Composite microscopy images were generated using Fiji by 
combining the three fluorescence channels. 
 
3.8.11 Endothelialization of perfusion microchannels 
The inner walls of printed vascular channels were functionalized by perfusing 0.5 mL 
aqueous solution of 10 mg mL−1 GelMA and 10 mg mL−1 LAP, followed by 2 min of UV-A 
illumination. Constructs were then immersed in HUVEC culture medium, sterilized by UV-C 
irradiation for 20 min in a laminar flow bench, and stored overnight. The functionalized 
channels were perfused with 0.5 mL HUVEC suspension (1 × 107 cells mL−1). The petri dish 
containing the construct was then fully filled with culture medium, sealed using Parafilm, 
and fixated onto the bottom of an acrylic box. Fast cell sedimentation in the channel leading 
to inhomogeneous cell coverage was overcome by repeated rotation of the construct 
around the channel axis during the seeding process: The box was initially turned upside 
down and incubated for 15 min. The box was rotated 90° clockwise and again incubated for 
15 min, and then rotated 180° counter-clockwise before incubating for another 15 min. The 
same cycle was conducted again to ensure that all parts of the channel walls were fully 
exposed to the cells. After 24 h incubation at 37 °C and 5% CO2, the channels seeded with 
HUVECs were perfused with 0.5 mL of culture medium containing 2 µg mL−1 calcein-AM and 
further incubated for 1 h. The samples were then characterized by confocal laser scanning 
microscope (LSM 700, Zeiss) using excitation at 488 nm. The vertical axis of the acquired 
confocal z-stack micrographs was corrected for the refractive index of the culture medium 
using the microscope software package (Zeiss Zen 2012 Black edition). 
 
3.8.12 Multi-furcated 3D perfusion culture constructs 
To demonstrate the perfusion of multi-furcated channel network as well as embedding 
cell-laden matrices in the culture chamber, constructs with a separate culture chamber and 
channel networks were printed in PEGDA. The channels were first perfused with 1 mL of 20 
µg mL−1 acryloxyethyl thiocarbamoyl rhodamine B (Sigma-Aldrich) solution containing 10 mg 
mL−1 LAP, followed by 2 min of UV-A illumination. The unreacted rhodamine molecules were 
flushed away using DI water. The constructs were then immersed in 3T3 fibroblast culture 
medium overnight to exchange the DI water for medium in the PEGDA hydrogel. Before 
harvesting cells, 3T3 fibroblasts were stained with calcein-AM (2 µg mL−1) in a culture flask 
for 1 h. Cell-laden GelMA solution was prepared by mixing warm (37 °C) LAP-containing 
GelMA solution in DPBS with an equivalent volume of 3T3 fibroblast suspension to reach 
final concentrations of 100 mg mL−1 GelMA, 5 mg mL−1 LAP and 5 × 106 cells mL−1. The culture 
chamber was then perfused with 0.5 mL of cell-laden GelMA solution, followed by 90 s of 
UV-A illumination. Both the intact sample and cross-sectional slices generated by manual 
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cutting were then immediately characterized by confocal laser scanning microscopy using 
excitation at 488 and 555 nm. 
To test if the culture chamber can be fully filled with matrices for cell embedding using 
pipetting rather than perfusion, 0.02 wt. % fluorescence microbeads (Ø 2 µm, FluoSpheres 
carboxylate-modified microspheres, yellow-green fluorescence, Thermo Fisher Scientific) 
instead of cells were encapsulated in 100 mg mL−1 GelMA solution containing 1 mg mL−1 LAP, 
loaded into the culture chamber and crosslinked through 2 min of UV-A irradiation. Samples 
were then sectioned and characterized using confocal laser scanning microscopy. 
For testing optimal LAP concentration for cell encapsulation, 200 µL of cell-laden pre-gel 
GelMA solutions with desired GelMA and LAP concentrations were added to a 48-well plate, 
followed by 2 min of UV-A irradiation. Then 500 µL of culture medium was added to each 
well. Samples were incubated for a desired period of time, with intermediate medium 
change every 2 days. Before visualization under confocal laser scanning microscopy using 
excitation at 488 and 555 nm, culture medium in each well was replaced with fresh medium 
containing 2 µg mL-1 calcein-AM and 2 µg mL-1 propidium iodide, and then incubated for 
another 1 h.   
 
3.8.13 Perfusion culture in printed 3D hydrogel microfluidic chips 
Before perfusion culture started, all the tubing was perfused by a large amount of 70% 
ethanol, followed by sterilized water using a multi-channel peristaltic pump (Watson-
Marlow, 205U). The surfaces of all equipment, including water bath, sample incubator, the 
pump and the outer surfaces of the tubing were wiped with 70% ethanol prior to 
experiment. Printed samples immersed in DMEM culture medium supplemented with 2% 
v/v penicillin-streptomycin, along with all the glass bottles are sterilized by UV-C illumination 
for 20 min (254 nm, UV sterilization cabinet, Cleaver Scientific). Prior to cell loading, 
sterilized samples were transferred to a laminar flow bench after immersion in DMEM 
medium for overnight to exchange the water in the hydrogel for culture medium. Cell-laden 
GelMA solution was prepared by mixing warm (37 °C) LAP-containing GelMA solution in 
DPBS with an equivalent volume of HT-29 cells suspension to reach final concentrations of 
100 mg mL−1 GelMA, 1 mg mL−1 LAP and 1 × 107 cells mL−1. Before cell loading, culture 
medium was partially removed so that samples were not submerged yet still moist, exposing 
the loading chamber to the atmosphere without severe dehydration of samples. The 
remaining liquid medium in the culture chamber was then completely removed by suction 
using a syringe connected to the needles as well as micro-tubing. The culture chamber was 
finally loaded by dropwise pipetting cell-laden GelMA solution into the chamber, followed by 
2 min of UV-A illumination. Before connecting samples to the pump, extra culture medium 
was added to petri dish to submerge samples again and the dish was capped by a lid with 
holes covered by Parafilm. Needles that were pre-filled with culture medium were then 
inserted to the channel connectors in samples and the perfusion rate was set at 70 µL/min. 
After culture, samples were sectioned by manual cutting. The generated cross-sectional 
75 
 
slices were stained with calcein-AM (2 µg mL−1, Invitrogen) and propidium iodide (PI, 2 µg 
mL−1, Sigma-Aldrich) for 1 h and then characterized by confocal laser scanning microscopy 
using excitation at 488 and 555 nm. 
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Chapter 4:  
Multi-material stereolithographic printing 
One of the current limitations of stereolithography is its limited capability of 
simultaneous printing of multiple materials. In contrast, extrusion-based printing can realize 
multi-material printing simply by implementing different printhead nozzles. Researchers 
have attempted multi-material stereolithographic printing by constantly changing and 
washing different resins between each layer fabrication.124,125,134,144,147,149–151,155,187,188 
However, such an approach requires manual labor and thus is time consuming. Therefore, 
true multi-material stereolithographic printing requires sophisticated chemistries that allow 
for independent photopolymerization of different monomers using different photoinitiators 
and wavelengths, which is not a trivial task to accomplish. Multi-material printing in 
stereolithography is of particular interest in constructing advanced in vitro cell culture 
models because incorporation of materials of different properties to fulfill various chemical, 
physical and mechanical requirements can potentially mimic the highly heterogeneous 
nature of in vivo system, and, equally important, integrate soft biomimicking hydrogels in a 
stiff self-contained chip unit. 
A dual material resin has previously been developed in the group based on both radical 
and cationic photopolymerization (Figure 4.1).189 Two different monomers, namely acrylate 
and epoxy, can be independently polymerized by their respective photoinitiators that are 
activated via different wavelengths, to form a construct with widely tunable elasticity, from 
highly stiff epoxy to highly compliant PEGDA. Although the current perfusion setup is fairly 
robust to conduct long-term perfusion culture experiments, such hydrogel material of 
intermediate compliance still needs to be handled with much caution. Therefore, it would be 
very useful to print a multi-material perfusion construct with stiff perimeters serving as user-
friendly world-to-chip interface (inlet/outlet) as well as with soft and diffusion-open 
interstitial volumes serving as cell culture unit. 
The postdoc, Esben K.U. Larsen, who developed the multi-material resin also conducted 
preliminary 3D printing test using the home-built polychromic printer. Sudan I, which 
absorbs light at both 365 and 450 nm, was selected as photoabsorber to improve vertical 
printing resolution. After the postdoc left the group, two tasks were carried out as a side 
project in this thesis: 1) optimize epoxy and PEGDA printing concentration so printed epoxy 
and PEGDA within the same construct would swell to a similar degree in immersion medium 
and thus mechanical strain due to swelling could be minimized; 2) print a perfusion 
construct using an optimized resin formulation with both stiff epoxy as perimeters and soft 
PEGDA as channel walls. 
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Figure 4.1 A) A schematic diagram of chemical reaction for CQ and CAT2 photoinitiation of the free 
radical polymerization of the acrylate (PEGDA) and the cationic polymerization of the epoxy 
component (EEC), respectively.189 B) Normalized absorption of the CQ and CAT2 photoinitiators and 
normalized emission spectra of the blue (450 nm) and UV (365 nm) light source.189 C) Compression 
A
B
C
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modulus of a solution containing 40% v/v EEC, 20% v/v PEGDA, CQ and CAT2 exposed with gradually 
increasing doses of either 450 or 365 nm light in a petri dish with the gradient of light duration and 
wavelength indicated. Error bars show the standard deviation of replicate measurements within the 
dish (n = 3).189 Adapted from ref. 189. 
 
4.1 Optimization of epoxy and PEGDA concentration 
Unpublished data: The authors would like to keep this section confidential until they are 
published. 
 
4.2 Printing and perfusion of dual-material constructs 
Unpublished data: The authors would like to keep this section confidential until they are 
published. 
 
4.3 Conclusion 
Although still in the preliminary stage, our multi-material stereolithographic printing 
approach demonstrates the potential for printing perfusion constructs with stiff material as 
construct perimeters as well as soft material as diffusion-open microchannel walls. More 
work needs to be done in the future to further optimize printing configuration, characterize 
the diffusion behavior within printed PEGDA, and study the cell compatibility of the printed 
constructs. 
 
4.4 Experimental section 
4.4.1 Materials 
Poly(ethylene glycol) diacrylate (Mn 700 g mol-1, PEGDA), camphorquinone (CQ), 
triarylsulfonium hexafluoroantimonate salts (CAT2) (50 wt. % in propylene carbonate), 3,4-
epoxycyclohexylmethyl 3,4-epoxycyclohexanecarboxylate (EEC), 1-phenylazo-2-naphthol 
(Sudan I), propylene carbonate (PC) and diethylene glycol diethyl ether (DGDE) were all 
purchased from Sigma-Aldrich and used as purchased. 
 
4.4.2 Projection stereolithography of dual-material constructs 
The printing procedures were almost the same as single material printing. Light exposure 
used both a 365-nm and 450-nm LED. The 3D design was exported separately as epoxy and 
PEGDA part, which were then independently sliced into a series of digital masks with a 
slicing thickness of 25 µm using the open-source slicer software instead of 20 µm used in 
single material printing. The resin was composed of 40% v/v PEGDA, 40% v/v EEC, 1 mg mL−1 
Sudan I,  20 mg mL−1 CQ and 30 mg mL−1 CAT2. Stock solutions of CQ and Sudan I were 
dissolved in DGDE. Prior to the addition of resin to the vat, aluminum foil was used to wrap 
the resin container to avoid premature crosslinking due to the ambient light. The digital 
masks from the two parts in the same layer were sequentially projected onto the vat bottom 
via their respective light source, UV exposure of 40 s for each epoxy layer and blue light 
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exposure of 70 s for each PEGDA layer. After printing, the object was immediately immersed 
in ethanol or PC for at least overnight to leach out remaining reagents and then transferred 
to a water bath prior to further use. 
 
4.4.3 Perfusion of dual-material printed constructs 
The same perfusion setup as mentioned before was applied. Briefly, blunt stainless 
needles (Ø 0.8 mm × 22 mm) were mounted to polytetrafluoroethylene (PTFE) tubing (Øinner 
0.30 mm and Øouter 0.50 mm) that was connected to a peristaltic pump (MasterFlex) via Luer 
Lock connectors. Printed constructs were fixated onto the bottom of a polystyrene petri dish 
using double sided adhesive tapes, and the petri dish filled with DI water. Aqueous solutions 
of both red and blue food dye (Dr. Oetker) were used as perfusion fluids. The tubing was 
pre-perfused with fluid to avoid bubbles, and the needles were inserted into the 3D printed 
inlet and outlet (Ø 0.7 mm). Pumping proceeded at a flow rate of 100 µL min−1 and the 
channel perfusion was recorded by a phone camera. 
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Chapter 5:  
Discussion 
5.1 The advantages of our proposed approach 
5.1.1 Direct embedding 3D complex and well-defined perfusion channel networks 
in hydrogel materials at high spatial resolutions 
Our stereolithographic hydrogel printing approach for direct embedding of 3D complex 
perfusion channel networks within diffusion-open materials has advantages over 
conventional 2D microfluidic systems engineered via molding and replication approaches, 
43,66,73–78 which are labor intensive and can usually produce channel networks restricted to 
planar architectures. Alternatively, 3D hydrogel microfluidic systems have been achieved 
using extrusion-based 3D printing in combination with sacrificial molding.112–117 However, 
due to the fact that extruded sacrificial filaments tend to fold or collapse under their own 
weight, perfusion channel networks constructed through this approach have been mostly 
rectilinear lattice architectures with limited 3D topological complexity, contrary to the multi-
furcated channel networks demonstrated in our approach. 
Our optimized printing configuration results in the faithful printing of perfusable 
microchannels of cross-section as small as 100 µm × 100 µm. Although it still cannot 
compare to the sub-micro resolution achieved in conventional 2D microfluidics engineered 
in research labs through photolithography and PDMS molding, such spatial printing 
resolution for perfusable microchannels has not yet been reported in hydrogel materials 
using stereolithography, to our best knowledge. By manipulating the diameters of printhead 
nozzles, sacrificial filaments with a diameter of about 50 µm have been extrusion printed 
and subsequently removed after hydrogel casting to form perfusable microchannels (Ø 50 
µm).115 Although smaller microchannels can be constructed using this approach, channels 
cannot be directly printed and are limited to cylindrical geometry. Furthermore, upon 
removal of sacrificial filaments, the formed microchannels are ultimately defined by their 
surrounding highly compliant hydrogels used for cell encapsulation, which challenge their 
long-term mechanical stability as well as structural fidelity. Researchers have also used 
undiluted highly crosslinked ultra-low MW PEGDA (Mn 250 g mol-1) to manufacture 
microchannels of cross-section as small as 18 µm × 20 µm by stereolithography.145,146 
However, the resulting constructs are so densely crosslinked that they resist swelling and are 
impermeable to water. Consequently, they are not considered as hydrogel materials and not 
suitable for constructing in vitro 3D cell culture models. 
Therefore, our proposed stereolithographic hydrogel printing approach has advantages 
over other existing methods for direct embedding 3D complex well-defined perfusion 
channel networks in hydrogel materials at high spatial resolutions. 
It should also be noted that we did not implement the smallest perfusable 
microchannels we can print for our perfusion culture constructs. Instead, we implemented 
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slightly larger microchannels (Ø 200 µm) because we wanted to achieve steady perfusion 
within a 3D complex channel network in a reproducible manner. As discussed in the previous 
chapter, small channels with sloped parts are more affected by the overcuring during 
printing, which is essential for manufacturing mechanically stable constructs through strong 
boding between neighboring layers. Since sloped parts are inevitable when constructing 
complex channel networks in a full 3D manner, small channels pose extra challenges for 
steady perfusion throughout the whole fluidic network in cases where random channel 
blockage can occur and difference in fluidic resistance among multiple channels complicates 
the fluidic behaviors. We have introduced a solution to overcome this issue by enlarging the 
sloped parts of channels to minimize the effect of overcuring, as discussed previously. 
Although effective, such approach requires more bulky structural elements in channel 
network designs, which might limit the density of channels that we can achieve in a full 3D 
manner. Extra work needs to be conducted in the future to fully benefit from the high spatial 
resolution of our stereolithographic hydrogel printing approach. However, we believe this is 
highly achievable. 
  
5.1.2 Diffusion-open and mechanically stable hydrogel constructs as self-contained 
3D microfluidic chips that allow for long-term steady perfusion cultures 
By using the PEGDA with suitable molecular weight, diffusion-open and mechanically 
stable hydrogel constructs have been achieved using our approach. The mechanical stability 
of printed constructs allows for long-term steady medium perfusion through channel 
network using a facile perfusion setup based on needles, microtubing and external pumping. 
The diffusional properties of printed constructs enables continuous diffusion of soluble 
factors such as oxygen and nutrients from channel network to culture volume, where cells 
are encapsulated in a different hydrogel material, and consequently can maintain a healthier 
cell culture in the long term. This is essential regardless of the intended applications of 
constructed 3D cell culture models, either as clinically useful replacements for damaged 
tissues or as in vitro models for scientific studies such as disease modeling and drug 
development. To our best knowledge, only few studies so far have reported long-term 
perfusion cell cultures in true 3D hydrogel microfluidic systems.116 Researchers have 
constructed a 3D cell culture entity that exceeded 1 cm in thickness with embedded lattice 
channel networks using extrusion printing in combination with sacrificial molding and 
consequently a healthy cell culture was maintained for weeks through medium perfusion.116 
However, upon removal of the sacrificial materials, the formed channel networks were 
ultimately defined only by the highly compliant hydrogels used for cell encapsulation. The 
resulting construct’s high compliance and limited long-term structural fidelity as well as 
stability thus challenge its use as self-contained perfusable in vitro systems. Consequently, 
an external perfusion chip device was integrated to maintain long-term perfusion and the 
fluidic channel networks were a bit distorted after perfusion (Figure 1.16B).116 
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Therefore, our approach has advantages over other existing methods for constructing 
mechanically stable, self-contained, 3D perfusable chip systems capable of supplying oxygen 
and nutrients through long-term medium perfusion in a reproducible manner. 
 
5.2 The limitations of our proposed approach 
5.2.1 Inability to encapsulate cells during fabrication and limited capability of 
incorporating multiple materials 
Our printed PEGDA hydrogels, although allowing for compound diffusion, are not 
suitable for cell encapsulation due to their relatively high crosslinking density. Therefore, 
cells are encapsulated in a different hydrogel material and subsequently incorporated post-
fabrication. PEGDA (Mn 700 g mol-1), instead of those highly compliant hydrogel materials 
used for cell encapsulation, was chosen because our current focus is to address the 
challenge in constructing mechanically stable, self-contained and perfusable chip systems 
capable of supplying oxygen and nutrients to an integrated 3D culture volume in a 
reproducible manner. However, it will be indeed of interest to further develop resin 
formulations that can simultaneously encapsulate cells and produce mechanically stable 
structures. A potential solution will be to print mixture of high and low MW PEGDA in order 
to keep a balance between mechanical stability and cell encapsulation capability. 
Furthermore, the stereolithographic process itself also poses challenges in simultaneous cell 
encapsulation: a) the cytotoxicity of formed radicals during photopolymerization and b) cell 
settlement in liquid resin during fabrication. By tuning photoinitiator concentration160 as well 
as using density gradient adjusting reagents to match the buoyant density of the cells with 
the resin,138 the cytotoxicity and cell settlement can be overcome. In contrast, extrusion 
based bioprinting techniques can inherently enable simultaneous cell encapsulation by 
simply mixing cell suspensions with bioinks.9,10,19,79,82,88 
Stereolithography is mostly restricted to the use of a single material while extrusion-
based technique can simultaneously print multiple materials by simply implementing 
multiple printhead nozzles. In our 3D hydrogel microfluidic culture chip system, a different 
type of material is incorporated post-printing by embedding a cell-laden hydrogel within the 
confines of a 3D printed PEGDA hydrogel chip. This approach can be scaled up by printing 
multiple culture volumes and subsequently incorporating multiple cellular matrices. 
However, post-fabrication cell loading can be challenging in terms of achieving effective 
filling of confined culture volumes, as discussed in the previous chapter. Our dual-material 
stereolithographic printing system, although demonstrating the ability to construct a PEGDA 
hydrogel perfusion channel network within the confines of stiff epoxy as a more robust 
“chip-to-the-world” interface, has some challenges that need to be overcome before living 
up to its full potential, such as difference in swelling properties among multiple materials 
and the channel connectivity at PEGDA/epoxy interface, as discussed in the previous chapter. 
Furthermore, adding a third material component in multi-material stereolithographic 
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printing is far from a trivial task. It requires even more sophisticated chemistries, where 
multiple components can be independently polymerized using different light wavelengths, 
as well as extensive studies regarding post-printing handling of the printed constructs where 
the interfaces between different components can maintain intact.  
Therefore, developing more advanced resin formulations that can encapsulate cells as 
well as allow for multi-material printing will be of particular interest in manufacturing 
advanced in vitro cell culture models that highly mimic the heterogeneous nature of in vivo 
system by stereolithography. 
 
5.2.2 Inability to establish direct cell-cell contact between cells cultured in different 
compartments within the same culture chip 
Our printed PEGDA hydrogel chips allow for diffusive paracrine signaling but not for 
direct cell-cell contact, either between the endothelial cells in the channel networks and the 
cells cultured in a separate printed compartment, or between the cells in different 
compartments, due to their nanoporous structures. This limitation may be circumvented by 
including micro-fenestrations in chip designs, as demonstrated previously in 2D microfluidic 
cell culture systems (Figure 1.7D,E).33,43,60,66,190 However, such micro-fenestrations not only 
need to be large enough to enable cell-cell contact but also small enough to retain their 
functions as structural confines, which usually are within the range from a few microns to 
tens of microns and consequently challenge the current spatial resolution that can be 
achieved by our printing configurations. Furthermore, direct cell-cell contact requires close 
proximity between cells (< 50 µm),191 indicating our printed channel networks and culture 
compartments should be only separated by very thin confines. This is challenging because 
the mechanical instability of a printed thin as well as perforated PEGDA layer might 
compromise the structural fidelity of the whole construct. Those challenges need to be 
addressed before we can implement micro-fenestrations in our chip designs to enable direct 
cell-cell contact. 
 
5.3 Summary and future work 
Extrusion bioprinting of cell-laden hydrogels used in combination with sacrificial molding 
is certainly a very useful and versatile technique, which is currently the most widely used 
technique for constructing 3D cell culture models. However, it also poses significant 
challenges in mechanical stability of a self-contained perfusable chip device as well as in the 
obtainable spatial resolution and 3D complexity of the perfusion fluidic network. In 
comparison, we have taken a distinctly different approach to address those challenges by 
manufacturing a mechanically stable and self-contained 3D perfusable chip that supplies 
oxygen as well as nutrients to maintain a long-term healthy culture of cells embedded in 
alternative soft hydrogels in a separate culture compartment, which is essential for 3D cell 
culture models regardless of the intended applications. However, our approach also poses 
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major challenges in cell encapsulation during fabrication, simultaneous incorporation of 
multiple materials and types of cells, as well as allowing for both short (juxtacrine signaling) 
and long distance (paracrine signaling) cell-cell communication. Those challenges limit the 
biological relevance/complexity that can be currently achieved by our approach in 
comparison with extrusion bioprinting. 
A promising direction in the future might be to develop a hybrid printing platform where 
extrusion printing is used in combination with stereolithography to produce 3D cell culture 
models with both structural and biological complexity. 
There are many things that we have not investigated in the scope of this study but might 
be of interest for the future work, such as how the endothelial cells seeded inside the 
channel networks would regulate compound transport, how flow rate would affect the 
outcome of perfusion cultures, and how the cellular microenvironment modulated by 
compound perfusion through channel network would affect various cellular behaviors other 
than cell viability.   
85 
 
Chapter 6:  
Conclusion and outlook 
The main aim of this work was to develop methods to 3D print diffusion-open and 
mechanically stable hydrogel constructs as self-contained 3D microfluidic chips at high 
spatial resolutions.  
One of the sub-goals of this project was to develop a cost-efficient resin for printing 
diffusion-open yet mechanically stable hydrogel constructs with embedded 3D microfluidic 
channels as artificial vascular-like network. By employing commercially available starting 
materials at reasonable cost, 3D PEGDA hydrogel microfluidic culture chips of intermediate 
compliance with embedded multi-furcated channel networks have been fabricated using an 
optimized stereolithographic 3D printing configuration. A systematic approach has been 
adopted to investigate the combined effect of multiple experimental parameters on the 
structural fidelity of printed microchannels. The optimized printing configuration results in 
the faithful printing of perfusable microchannels of cross-section as small as 100 µm × 100 
µm. By characterizing the time dependent diffusion distance of a perfused dyed liquid inside 
a printed microchannel, well-fitted diffusion kinetics have been observed within printed 
PEGDA hydrogels. Cellular components are incorporated post-fabrication by embedding cell-
laden matrices within the confines of printed PEGDA culture compartments. 
Another sub-goal of this project was to develop a facile platform for steady and long-
term perfusion of printed hydrogel microfluidic culture chips. By employing commercial 
flexible micro-tubing and blunt syringe needles, a facile perfusion setup has been developed 
and resulted in stable leak-free perfusion of printed hydrogel culture chips for at least a 
week. Due to the mechanical stability of printed hydrogel culture chips, needles mounted to 
the micro-tubing can be inserted into printed channel connectors, and the connection 
between the micro-tubing and external pump can be easily made via widely used Luer locks 
and regular tubing. 
A third sub-goal of this project was to develop a long-term perfusion culture platform 
using printed hydrogel 3D microfluidic culture chips. Due to the simplicity of the established 
perfusion setup, all equipment can be easily sterilized separately. Physicochemical 
properties that are important for a cell culture environment such as pH, temperature and 
oxygen tension, are maintained by implementing a commonly used circulating water bath, a 
microscope stage incubator and an external gas supply. Long-term perfusion culture for a 
week within printed hydrogel microfluidic chips has been demonstrated without notable 
contamination using this facile platform. The incorporated microfluidic channel network has 
proven to be essential to maintain a healthy 3D cell culture in the long term. 
By the end of this project, all the main goals have been achieved. In addition, multi-
material stereolithographic printing has also been attempted in this project. Although still in 
the preliminary stage, our dual-material printing approach based on independent 
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photopolymerization mechanisms has demonstrated the potential for manufacturing 
perfusion systems with heterogeneous materials fulfilling different purposes, namely highly 
stiff epoxy component serving as structural supports and soft PEGDA component serving as 
cell culture unit. 
Two printing systems have been studied in this project, one is based on a commercial 
stereolithography printer and the other is based on a home-built polychromic 
stereolithography printer. The commercial system offers limited flexibility in changing 
experimental configurations, but is a good start point for researchers who want to work on 
3D printing without experience or access to customized systems. We believe the presented 
approach in this thesis for modifying the commercial system to print hydrogel materials can 
serve as a useful guideline for beginners. On the other hand, the home-built system requires 
expertise in machinery and optics for construction, but offers great flexibility in exploring 
multiple experimental parameters as well as better resolution. It should be noted that 
although the construction of the printer requires trained personnel, the use of the optimized 
system is quite straightforward and demands minimal labor.   
In summary, we have addressed the challenge of construction as well as perfusion of a 
mechanically stable and self-contained 3D perfusable chip system that supplies oxygen and 
nutrients to maintain a long-term healthy culture of cells embedded in alternative soft 
hydrogels in a separate printed culture compartment via a reproducible and highly 
automated process. We believe this proposed approach will enable faster translation of 3D 
in vitro chip culture technologies to become a standard accessible and reliable technology 
both in the biological and medical sciences and, in particular, in industrial and clinical 
settings.  
However, some major challenges specifically relevant to our approach need to be 
addressed in the future work, such as cell encapsulation during fabrication, simultaneous 
incorporation of multiple materials and types of cells, as well as allowing for both short 
(juxtacrine signaling) and long distance (paracrine signaling) cell-cell communication. Those 
challenges may be overcome by developing more advanced resin formulations that can 
simultaneously produce mechanically stable constructs and encapsulate cells, as well as by 
incorporating micro-fenestrations into our chip designs. Also, future work has to be 
performed to validate the proposed approach with respect to its use as fully functional in 
vitro models. So far only cell viability has been investigated in this project. Future studies 
should focus on detailed investigation of long-term cell culture behavior regarding specific 
functionalities in 3D when the cellular microenvironment is modulated by compound 
perfusion through the vascular network-like constructs.   
In addition, some general challenges presented in in vitro 3D cell culture models are also 
worth special attention in the future.  
Firstly, characterization methods need to be developed accordingly in order to fully 
benefit from a complex 3D culture model. Commonly used end-point assays in biological 
research cannot be easily applied to 3D culture models without complex 3D structural 
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elements obstructing the assay. Meanwhile retrieving or abstracting cells from the models is 
not a trivial task. Furthermore, optical imaging in 3D is very challenging due to light 
scattering among biomaterials and cells. Few reports have been published on imaging 
through an intact 3D cell culture entity.192,193 On the other hand, sectioning of samples to 
obtain perfect slices for microscopy is also difficult, which usually requires sophisticated 
equipment not only for sectioning but also for preserving biological structures during the 
process. Therefore, versatile characterization methods are in great demand for abstracting 
valuable information from complex 3D culture models more efficiently. 
Secondly, due to the complexity of native biological systems, it is still unclear to what 
degree the in vitro microenvironment should be engineered to elicit desired biological 
response. Such task calls for continuous communications and collaborations among 
researchers with different expertise, such as material chemists, biologists and engineers. 
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